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Figure.8 Images of S.pombe wild type pREP41DS-GFP grown with thiamine, 
showing cytoplasmic GFP, though this appears to be excluded from 
vacuoles, bright spots indicate the possible presence of small 
aggregates. 
Figure.9 Images of S.pombe wild type pREP41DS-GFP grown without 
thiamine, showing cytoplasmic GFP, which again appears to be 
excluded from vacuoles, bright spots indicate the possible presence 
of fewer larger aggregates. 
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Figure.10 Western Blot showing the presence of D-Synuclein-GFP as a 
monomer in the sample grown with thiamine where expression is at 
low levels and as both a monomer and dimer in the sample grown 
without thiamine, where expression is not inhibited and so at a 
higher level. 
Figure.11 OD600 Growth Curves for S.pombe wild type containing 
pREP41GFP or pREP41DS-GFP. 
Figure.12 Western Blot which shows the presence of D-Synuclein-GFP at the 
expected MW for a monomer in the sample grown with thiamine 
where expression is at low levels, but only in the supernatant. Bands 
RIWKHH[SHFWHG0:¶VIRUERWKPRQRPHUDQGGLPHUZHUHVHHQLQWKH
supernatant of the sample grown without thiamine where 
expression is not inhibited and so at a higher level Possible 
damaged fragments of dimer were seen in both samples grown 
without thiamine. Dimer and dimer fragments only were seen in the 
pellet grown without thiamine. 
Figure.13 OD600 Growth Curves for a naa25' S.pombe strain containing 
pREP41GFP or pREP41DS-GFP grown with and without thiamine. 
Figure.14 Images of naa25' S.pombe containing pREP41GFP grown both 
with and without thiamine had a low levels of fluorescence. Bright 
spots indicate the presence of small aggregates that are excluded 
from the nuclei. Images of naa25' S.pombe containing pREP41DS-
GFP grown with thiamine, have low levels of fluorescence indicating 
the presence of low levels of D-Synuclein-GFP which appears to be 
dispersed through the cytoplasm but excluded from vacuoles. The 
image of naa25'S.pombe containing pREP41DS-GFP grown 
without thiamine, has higher levels of fluorescence indicating that a 
higher level of D-Synuclein-GFP was produced. This appears to be 
dispersed through the cytoplasm, but excluded from vacuoles in 
some cells. But in other cells bright spots indicate that the D-
Synuclein-GFP may be starting to form small aggregates as with 
GFP alone.  
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Figure.15 Western Blots that compare the presence ofDSynuclein-GFP as a 
monomer in the samples grown with thiamine, but seen only in the 
supernatant. Both monomer, dimer and fragments of dimer were 
seen in both of the ±thiamine supernatants where expression is not 
inhibited and so at a higher level. Clear bands were only seen at the 
weight expected for dimers in both of the ±thiamine pellets, faint 
bands were also visible also slightly below this weight possibly due 
to damaged dimer fragments. 
Figure.16 Images of wild type S.pombe pREP41DS-Cerulean3 grown with 
thiamine to repress vector expression. At low levels of vector protein 
expression very little fluorescence could be observed and so 
produced only faint fluorescent images, where the fluorescence 
appears to be cytoplasmic. Phase images were included to clearly 
show the cells being observed. 
Figure.17 Images of wild type S.pombe pREP41DS-Cerulean3 grown without 
thiamine. At higher levels of vector protein expression far more 
fluorescence could be detected. In some cells with slightly lower 
levels this appears to be cytoplasmic, with a slight concentration at 
the poles. In others with higher levels it appears to be excluded from 
vacuoles and concentrated at the separation membrane. 
Figure.18 Images of wild type S.pombe pREP41DS-Cerulean3 grown with 
thiamine. Again low levels of vector protein expression led to very 
little fluorescence being detected in comparison to the images of 
induced cells. The fluorescence observed still appears to be 
cytoplasmic but in one cell did seem to be concentrated at the 
separation membrane (red arrow). The FM4-64 did not stain all of 
the cells clearly but some have clearly stained vacuole membranes. 
Figure.19 Images of. wild type S.pombe pREP41DS-Cerulean3 grown without 
thiamine Again higher levels of vector protein expression led to far 
more fluorescence being detected. In some cells with slightly lower 
levels this appears to be more cytoplasmic. In others with higher 
levels it appears to be excluded from vacuoles but present within 
the nucleus and concentrated at the separation membrane. Two 
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cells appear to have aggregates on the membrane (red arrows). The 
FM4-64 did not stain all of the cells clearly but some have clearly 
stained vacuole membranes and is excluded from the nucleus. 
Figure.20 Images of S.pombe pINT41DS-Cerulean3, grown for 1 day with 
thiamine, stained with FM4-64. At the very low levels of vector 
protein expression created by a single copy of the integrated DS-
Cer3 vector in the presence of thiamine only extremely low levels of 
fluorescence could be detected. Despite using image enhancement 
only very faint cerulean images could be produced. The images 
obtained using FM4-64 dye  and phase images show very 
misshapen cells, some of which also show multiple septa (red 
arrows), very thick septa (blue arrow) and unusual shaped vacuoles 
(green arrow). 
Figure.21 Images of S.pombe pINT41DS-Cerulean3, grown for 1 day without 
thiamine, stained with FM4-64. At the higher levels of vector protein 
expression created by a single copy of the integrated DS-Cer3 
vector without thiamine, compared to growth with thiamine, very low 
levels of fluorescence could still only be detected. Despite using 
image enhancement only very faint cerulean images could be 
produced. The images obtained using FM4-64 dye and phase 
images show very misshapen cells, some of which also show 
multiple septa (red arrows) and unusually large vacuoles (green 
arrow). 
Figure.22 Images of S.pombe pINT41DS-Cerulean3, grown for 2 days with 
thiamine, stained with FM4-64. After 2 days of growth with thiamine 
very low levels of vector protein expression created by a single copy 
of the integrated DS-Cer3 vector, meant that only extremely low 
levels of fluorescence could be detected. Despite using image 
enhancement only very faint cerulean images could be produced. 
The images obtained using FM4-64 dye  and phase images show 
very misshapen cells, some of which also show multiple septa (red 
arrows) and very thick septa (blue arrow). Cell vacuoles can no 
longer be clearly seen. 
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Figure.23 Images of S.pombe pINT41DS-Cerulean3, grown for 2 days without 
thiamine, stained with FM4-64. After 2 days growth without thiamine 
the higher levels of vector protein expression, compared to cells 
grown with thiamine, created by a single copy of the integrated DS-
Cer3 vector, created only low levels of fluorescence. Despite using 
image enhancement only very faint cerulean images could be 
produced. The images obtained using FM4-64 dye and phase 
images show very misshapen cells, some of which also show 
multiple septa (red arrows) and very thick septa (blue arrow). 
Vacuoles can only be seen clearly in a few cells (green arrow). 
Some cells also appear to be producing bleb like structures (white 
arrows). 
Figure.24 Coomassie stained gel, the two post induction protein samples on 
the right, show a large increase in protein produced, compared with 
pre induction. 
Figure.25 Images of BL21DE3 DS-Cerulean3 cells and BL21+NatBDS-
Cerulean3 cells, Pre induction and 1, 2 and 3 hours post induction. 
BL21DE3 DS-Cerulean3 cells show only low levels of fluorescence, 
which appeared to be cytoplasmic. In the image taken at 1 hour post 
induction, more fluorescence was seen, this still appeared to be 
predominantly cytoplasmic, but some brighter areas appeared to 
show the start of some localisation and possible aggregate 
formation. In the image taken at 2 hours post induction. Some 
fluorescence still appeared to be cytoplasmic. However, some cells 
appeared to have bright concentrations of fluorescence, possibly 
indicating the presence of aggregates or blebbing around the 
outside of the cells. Other cells appeared to have ribbon like areas 
of localisation, predominantly but not exclusively, on the inside of 
the plasma membrane. In the image taken at 3 hours post induction, 
there was a complete mix of appearances. Some cells still appeared 
to have cytoplasmic Cerulean3. Some have areas of bright 
fluorescence or possible aggregates or blebbing around the outside 
of the cell. Some have ribbon like concentrations within the cell and 
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some have a mixture of these appearances. This variation may be 
due to differing concentrations of plasmid present in different cells. 
It was not possible to take images of BL21+NatBDS-Cerulean3 
cells, Pre induction, as the level of fluorescence was too low. In the 
image of BL21+NatBDS-Cerulean3 cells taken at 1 hour post 
induction. Fluorescence appeared to be mainly cytoplasmic. A few 
cells have areas that seem to have a slightly higher level of 
fluorescence. The images of BL21+NatBDS-Cerulean3 cells, taken 
at 2 hours post induction show lots of blebbing around some cells 
together with some of the ribbon like localisation. In the images of 
BL21+NatBDS-Cerulean3 cells, taken at 3 hours induction, only a 
few blebs or aggregates were visible on the outside of the cells. 
However the ribbon like localisation was seen to be more dominant 
and more clearly defined.   (Scale-1Pm) 
Figure.26 Images of slices of thin sectioned BL21DE3 DS-Cerulean3 cells 
taken at 2 hours induction using TEM. The TEM images show clear 
blebbing on the outside of the cells producing unacetylated    
D-Synuclein-Cerulean3. The blebs appear to be membrane bound 
structures being released from the cell surface. 
Figure.27 Images of slices of thin sectioned  BL21+NatBDS-Cerulean3 cells 
producing acetylated D-Synuclein-Cerulean3 were seen to be 
producing lots of smaller blebs. They were also seen to be 
producing structures with a tubular network. These seemed to 
originate on the inside of the plasma membrane and build up into 
the inside of the cell. Some cells appear to be having difficulty 
dividing, possibly due to the presence of these structures (see arrow 
on third image). These structures seem to be what creates the 
ribbon like appearance seen in the 3 hour fluorescent microscopy. 
Figure.28 4 TEM images of BL21+NatBDS-Cerulean3 cells, using a darker 
Osmium tetroxide and Thiocarbohydrazide stain, to enhance the 
appearance of the internal tubular structures. Red arrows indicate 
cells that appear to be having difficulty dividing. 
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Figure.29 Image of BL21+NatB cells containing an empty vector. No immuno 
staining could be seen indicating an absence of D-Synuclein. 
Figure.30 Image of BL21+NatADS-Cerulean3 cells, showing immuno staining 
to be concentrated in the areas where the tubular networks were 
seen in earlier images, in the areas inside the plasma membrane. 
Figure.31 Image of BL21+NatBDS-Cerulean3 cells showing immuno staining, 
which again appears to be concentrated in the areas where the 
tubular networks were seen previously. 
Figure.32 Graph to compare growth rates, of acetylated and unacetylated    
D-Synuclein and an empty vector using OD600. 
Figure.33 Coomassie stained 4-12% Bis-Tris gel and western blot of 
BL21+NatADS-Cerulean3 cells and BL21NatBDS-Cerulean3 cell 
extracts. 
Figure.34 Fluorescent growth curve comparing BL21+NatA DS-Cer3 and 
BL21+NatB DS-Cer3 cells producing acetylated and unacetylated 
D-Synuclein-Cerulean3, grown with and without the addition of IPTG 
Figure.35 Images of BL21+NatBDS-Cerulean3 cells, stained with FM4-64. 
Blebs can be seen in the Cerulean3 images (Red arrows) (Scale 
1Pm). 
Figure.36 Images of BL21+NatB-GFP cells, stained with FM4-64 (Scale 1Pm). 
Figure.37 Fluorescent scans of cell cleared culture medium, from cultures of 
BL21+NatA DS-Cer3, BL21+NatA DS, BL21+NatB GFP, 
BL21+NatB DS-Cer3 and   BL21+NatB DS cells, 90 hours post 
induction, indicating the presence of fluorescent proteins. 
Figure.38 Images of BL21+NatADS-Cerulean3 cells 24 hours Post Induction, 
obtained using Phase and Fluorescent light microscopy (stained 
with FM4-64. Scale 1Pm), TEM and Immuno EM. 
Figure.39 Images of BL21+NatBDS-Cerulean3 cells 24 hours Post Induction, 
obtained using Phase and Fluorescent light microscopy (stained 
with FM4-64. Scale 1Pm), TEM and Immuno EM. Red arrows 
indicate cells that appear to be having difficulty dividing. 
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Figure.40 Images of BL21+NatADS cells 24 hours Post Induction, obtained 
using Phase and Fluorescent light microscopy (stained with FM4-
64. Scale 1Pm), TEM and Immuno EM. 
Figure.41 Images of BL21+NatBDS cells 24 hours Post Induction, obtained 
using Phase and Fluorescent light microscopy (stained with FM4-
64. Scale 1Pm), TEM and Immuno EM. Red arrows indicate cells 
that appear to be having difficulty dividing. 
Figure.42 Images of BL21+NatB GFP cells 24 hours Post Induction, obtained 
using Phase and Fluorescent light microscopy (stained with FM4-
64. Scale 1Pm), TEM and Immuno EM. 
Figure.43 Images of BL21+NatA DS-Cerulean3 cells 90 hours Post Induction, 
obtained using Phase and Fluorescent light microscopy (stained 
with FM4-64. Scale 1Pm) and TEM. 
Figure.44 Images of BL21+NatB DS-Cerulean3 cells 90 hours Post Induction, 
obtained using Phase and Fluorescent light microscopy (stained 
with FM4-64. Scale 1Pm) and TEM. 
Figure.45 Images of BL21+NatA DS cells 90 hours Post Induction, obtained 
using Phase and Fluorescent light microscopy (stained with FM4-
64. Scale 1Pm) and TEM. What the spore like structures are is 
unknown. The white spots are holes where the resin used to fix the 
cells was unable to penetrate into these structures. 
Figure.46 Images of BL21+NatB DS cells 90 hours Post Induction, obtained 
using Phase and Fluorescent light microscopy (stained with FM4-
64. Scale 1Pm) and TEM. The images appear to show a large 
proportion of dead or dying cells. 
Figure.47 Images of BL21+NatB GFP cells, 90 hours Post Induction, obtained 
using Phase and Fluorescent light microscopy (stained with FM4-
64) and TEM. What the spore like structures are is unknown. The 
white spots are holes where the resin used to fix the cells was 
unable to penetrate into these structures. 
Figure.48 Coomassie stained 4-12% Bis-Tris gel and Western Blot analysis of 
cell cleared culture media, 90 Hours post induction.   
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Figure.49 Coomassie stained 4-12% Bis-Tris gel and Western Blot analysis of 
protein from cells taken, pre and 90 Hours post induction.   
Figure.50 Plasmid map for the pETDuet plasmid used for the production of 
just one or simultaneous production of two recombinant proteins. 
Figure.51 Plasmid map showing the locations of the genes for D-Synuclein-
Cerulean3 and cydAB-mCherry proteins,within the pETDuet 
plasmid. 
Figure.52 BL21DE3 DS-Cerulean3+cydAB-mCherry cells expressing both    
D-Synuclein-Cerulean3 and cydAB-mCherry The DS-Cer3 appears 
to be at lower levels in the cytoplasm and higher levels within blebs, 
cydAB-mCherry appears to be localised to the cell membrane. 
(Scale 1Pm) 
Figure.53 BL21+NatB DS-Cerulean3+cydAB-mCherry cells expressing both    
D-Synuclein-Cerulean3 and cydAB-mCherry. The DS-Cer3 appears 
to be at slightly higher levels at cell membranes and at much higher 
levels in structures giving a stripy appearance to the brightest cell, 
cydAB-mCherry appears to be at slightly higher levels at cell 
membranes and poles. (Scale 1Pm). 
Figure.54 BL2+1NatB DS-Cerulean3+cydAB-mCherry cells expressing both    
D-Synuclein-Cerulean3 and cydAB-mCherry with the appearance of 
both ribbons and blebbing (Scale 1Pm). 
 Figure.55 Images of BL21DE3 and BL2+1NatB cells with plasmids containing    
DS-Cerulean3, DS-Cerulean3+cydAB-mCherry or cydAB-mCherry 
genes. Cells are compared expressing either D-Synuclein-
Cerulean3, cydAB-mCherry or both simultaneously. (Scale 1Pm, 
except where 5Pm stated on image). 
Figure.56 Cerulean3 fluorescent growth curve, for BL21DE3 and    
BL21+NatB cells with plasmids containing DS-Cerulean3,    
DS-Cerulean3+cydAB-mCherry or cydAB-mCherry genes.   
Figure.57 mCherry Fluorescent growth curve, for BL21DE3 and      
BL21+NatB cells with plasmids containing DS-Cerulean3,    
DS-Cerulean3+cydAB-mCherry or cydAB-mCherry genes. 
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Figure.58 Coomassie stained gel for whole cell protein samples from 
BL21DE3 and BL21+NatB cells with plasmids containing   
DS-Cerulean3, DS-Cerulean3+cydAB-mCherry and cydAB-
mCherry genes, pre induction and 2 hours post induction. 
Figure.60 Coomassie stained  4-12% Bis-Tris gel for 5 day post induction 
protein samples from cell cleared culture medium from cultures of 
BL21DE3 and BL21+NatB cells containing DS-Cerulean3, DS-
Cerulean3+cydAB-mCherry and cydAB-mCherry. 
Figure.60 Western Blots using anti D-Synuclein (top) and anti mCherry 
(bottom) on whole cell protein samples taken 2 hours port induction 
from cultures of BL21DE3 and BL21+NatB cells containing    
DS-Cerulean3, DS-Cerulean3+cydAB-mCherry and cydAB-
mCherry. 
Figure. 61 Plasmid map to show the relative positions of the genes coding for 
D-Synuclein-Venus-Amino half and DSynuclein-Venus Carboxyl 
half within the pETDuet plasmid. 
Figure.62 Images of BL21+NatA (left) and BL21+NatB (right) cells containing    
DS-VC observed by Phase microscopy. No Venus signal was 
visible, showing that the Carboxyl half of the Venus Protein does not 
produce fluorescence by itself. 
Figure.63 Images of BL21+NatA DS-VN DS-VC cells producing D-Synuclein-
Venus Amino half and D-Synuclein-Venus Carboxyl half have 
Venus fluorescence, showing both blebbing around cells and a 
ribbon like appearance within many cells. This indicates the 
presence of D-Synuclein oligomers, both within the cells and within 
the blebs. 
Figure.64 Images of BL21+NatB DS-VN DS-VC  cells producing acetylated    
D-Synuclein-Venus Amino half and acetylated D-Synuclein-Venus 
Carboxyl half also have Venus fluorescence, showing both blebbing 
around cells and a ribbon like appearance within cells. This again 
indicates the presence of D-Synuclein oligomers both within the 
cells and within the blebs (Scale 1Pm). 
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Figure.65 Coomassie stained 4-12% Bis-Tris gel examining BL21+NatADS-
VC, BL21+NatBDS-VC, BL21+NatADS-VN DS-VC and 
BL21+NatBDS-VN DS-VC whole cell proteins, Pre and 3 Hours Post 
induction.  Post induction the DS-VC samples show the production 
of D-Synuclein-Venus-Carboxyl half (24.1kDa) and the DS-VN DS-
VC samples show the production of both D-Synuclein-Venus-
Carboxyl half and D-Synuclein-Venus-Amino half (32.1kDa). 
Figure.66 Coomassie stained 4-12% Bis-Tris gel and Western Blot, examining 
protein precipitated from, Cell cleared culture media from 
BL21+NatADS-VN DS-VC and BL21+NatBDS-VN DS-VC, cultures 
at 24, 48, 120 and 144 hours post induction. 
Figure.67 Coomassie stained 4-12% Bis-Tris gel showing separate production 
of D-Synuclein-Venus-Amino half and D-Synuclein-Venus-Carboxyl 
half in BL21DE3 cells using vectors DS-VN and DS-VC. 
Figure.68 Images of BL21DE3 cells containing DS-VN observed by Phase 
microscopy (left). No Venus signal was visible and so no images 
possible (right), showing that the Amino half of the Venus Protein 
does not produce fluorescence by itself. 
Figure.69 Venus fluorescent growth curve for BL21DE3 and BL21+NatB cells 
containing DS-VC, DS-VN DS-VC and DS-VN vectors. A gradual 
increase in fluorescence was seen with the cells containing DS-VC, 
and DS-VN vectors alone.  A rapid initial increase in fluorescence 
was seen with both cultures containing DS-VN DS-VC. This rate 
reduced after 3hours with BL21NatBDS-VN DS-VC cells and a 
decrease in fluorescence was seen with BL21DE3DS-VN DS-VC 
cells after 18 hours. 
Figure.70 FPLC trace showing protein containing fractions collected, 
determined by absorbance at 260 and 280nm, from purification of 
BL21+NatB DS-Cerulean3 Cell Cleared Culture Media. 
Figure.71 Coomassie stained 4-12% Bis-Tris gel showing protein content of 
fractions from purification of BL21+NatB DS-Cerulean3 from cell 
cleared culture media. 
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Figure.72 Western Blot using anti D-Synuclein antibody on fractions J2 and J4 
(Figure 68) from the purification of BL21+NatB DS-Cerulean3 from 
cell cleared culture media. 
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ABSTRACT 
Alpha-Synuclein (DS) is a small, 140 amino acid, neuronal protein, found 
predominantly in the presynaptic terminals of neurons. Although the precise cellular 
IXQFWLRQRIĮ6UHPDLQVXQNQRZQLWLVNQRZQWREHFULWLFDOLQWKHSDWKROogy of a number 
of neurodegenerative dLVRUGHUVLQFOXGLQJ3DUNLQVRQ¶V'isease (PD) and other related 
GHPHQWLDV$FRPPRQV\PSWRPDWLFIHDWXUHRI3'DQGĮ6DVVRFLDWHGGLVHDVHVWDWHV
LVWKHDJJUHJDWLRQRIPLVIROGHGĮ6LQWR/HZ\ERGLHVĮ6LVVXEMHFWWRDQXPEer of post-
translational modifications, including amino-terminal (Nt) acetylation and is known to 
bind to membranes, both are believed to effect oligomer formation and the 
DFFXPXODWLRQRIĮ6DJJUHJDWHV ,Q WKLVSURMHFW ,DPXVLQJGLIIHUHQWPLFURELDOPRGHO
systems to examine the effect of Nt-acetylation on membrane binding and oligomer 
IRUPDWLRQDQGWKHLUHIIHFWRQWKHDFFXPXODWLRQRIĮ6DJJUHJDWHVZLWKLQWKHFHOO7KH
first model system used is the bacteria E. coli, in which we are making use of a novel 
Nt-acetylation system developed within this lab. The second model system being used 
is the fission yeast Schizosaccharomyces pombe, which allows us to use molecular 
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1. CHAPTER I: INTRODUCTION    
 
1.1 D-Synuclein  
D-Synuclein is one of the most abundant proteins in cells. It is found predominantly in 
the presynaptic terminals of neurones and can also be found in red blood cells (Bartels 
T et al 2011), the heart, muscles, and other tissues (Genetics Home Reference: 
SNCA". U.S. National Library of Medicine. 2013). It is a small 140 amino acid protein, 
that is normally soluble, but which forms aggregates in several disease states. The 
SNCA gene codes for D-Synuclein.  
D-Synuclein was first identified in E-amyloid plaques in the brain of patients with 
$O]KHLPHU¶VGLVHDVHEXWLVPRVWO\DVVRFLDWHGZLWK3DUNLQVRQ¶VGLVHDVH3DUNLQVRQ¶V
disease is one of a number of neurodegenerative disorders called                       
D-Synucleinopathies which also includes dementia with Lewy bodies and multiple 
system atrophy. (Kim WS et al. 2014) 
D-Synuclein is subject to many different post translational modifications and is also 
known to interact with lipids, phospholipids and other proteins. It is not fully understood 
how these interactions affect D-Synuclein structure and function. (Paleologou. et al. 
2012) 
 There are several actions proposed for D-Synuclein but the exact function remains 
unknown. (Snead D. 2014) 
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1.2 The structure of D-Synuclein 
D-Synuclein was long thought to exist primarily as a natively unfolded protein 
monomer, found mainly in the presynaptic terminals of neurones. The protein is made 
up of three domains, the N-terminal region (residues 1 to 60) which contains lysine-
rich, imperfect 11 amino acid repeats, that are important in membrane binding and     
D-helix formation. The central non-amyloid beta component (NAC) region (residues 61 
to 95) which is predominantly composed of hydrophobic residues, this region is 
required for D-Synuclein aggregation. The third domain is the C-terminal region 
(residues 96 to 140) which is acidic and proline rich, this domain is found in a 
disordered conformation and has been implicated in interactions with proteins, metals 
and small molecules. (Kim WS. 2014. Pratt MR. 2015). 
 
 
 The N-terminal region has been shown to undergo a change into an amphipathic         
D-helix on membrane binding. The lipid composition and membrane curvature, can 
effect this binding, both electrostatic and hydrostatic interactions seem to contribute, 
with enhanced binding to vesicles with increased curvature and negative charge. 
Different helical membrane-bound conformations have been observed, including a 
short helix at the N-terminal with the remainder of this domain unbound, on 
phospholipid vesicles. An extended helix of approximately 100 residues and a broken-
helix conformation in which the extended-helix is broken into two distinct helices 
separated by a non-helical linker region (residues 39 to 45) have both been observed 
in the context of detergent micelles and lipid vesicles. (Snead D et al.2014) 
Figure.1. Structure of alpha-Synuclein bound to lipid vesicles. (Ritchie C.M. et al 
2012) 
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N-terminal acetylation has also been shown to increase helicity at the N terminus and 
electrostatic charge and to increase membrane affinity with moderately charged 
vesicles. (Dikiy I et al. 2014) (Maltsev A.S et al. 2012). 
 
 Evidence is now emerging, that D-Synuclein exists naturally as a tetramer, which may 
resist aggregation, though some are sceptical of this (Maltsev A.S et al. 2012. Fauvet 
B et al. 2012). It is becoming apparent, that tetramers can only be isolated using very 
gentle, non-denaturing purification methods (Bartels T et al. 2011. Luth E.S et al. 2015.  
Wang W, et al 2011) and that they may only form with acetylated D-Synuclein. (Trexler 
A.J et al. 2012). This may account for tetramers not being seen with D-Synuclein 
produced in E.coli, which is not acetylated or where heating is used in the protein 
purification. Different arrangements for tetramer or oligomer formation have also been 




Figure. 2. Scheme of a physiological folding pathway fRUĮ-Synuclein. (Burré J et al. 
2014) showing a proposed oligomer formation. 
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 The oligomer formation (Figure.2.) may be the start of aggregate formation, rather 
than a progression from physiological tetramers. This is possibly due to the use of 
recombinant D-Synuclein which is not acetylated and may not therefore be able to 




Figure.3. 0RGHOIRUFRPSDFWĮ-Synuclein tetramer based on EM reconstruction and 
PRE. Helices are represented as cylinders. N indicates the N-terminal of the protein, 
ZLWKWKHILUVWKHOL[ĮUHSUHVHQWHGE\JUHHQ-ended cylinder) ending at ׽residue 43. 
7KHVHFRQGKHOL[ĮEOXHHQGHGVWDUWV׽residue 50 and ends at residue 103 
(marked C). The remainder of the polypeptide, which is expected to be disordered, is 
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1.3 The action of D-Synuclein 
 The exact action of D-Synuclein is unknown, but there are several theories. 
 As D-Synuclein is predominantly found in the presynaptic terminals of neurons and is 
known to bind synaptic vesicles it is largely thought to be involved in maintaining a 
supply of synaptic vesicles in presynaptic terminals and to act as a chaperone in the 
formation of SNARE complexes, experiments using SNCA knockout mice have also 
shown an effect on memory and cognitive function. (Kim W.S. et al. 2014. Burré J. et 
al 2014). 
 However D-Synuclein is also found in large amounts in Red Blood Cells (Bartels T et 
al. 2011) and is also thought to potentially interact with other cellular membranes, 
including the inner nuclear membrane, mitochondrial membranes, the plasma 
membrane and with lipid rafts and fatty acids. These other potential sites of                     
D-Synuclein action could indicate a more widespread or general function for                   
D-Synuclein 
 
Figure.4. Cellular membranes, targets and pathways potentially involved in the 
normal, physiological functions of alpha-Synuclein. (Snead D et al. 2014)  
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1.4 Post translational modifications of D-Synuclein 
 There are several post-translational and co-translational modifications that                     
D-Synuclein can undergo, including phosphorylation, ubiquitination, nitration and         
N-terminal acetylation. (Kim W.S. et al 2014. Pratt. Et al. 2015).  
 Phosphorylation is seen as the most common post-translational modification. In 
dementia with Lewy Bodies, approximately 90% of insoluble D-Synuclein was found 
to be phosphorylated at S129, compared to 4% in soluble cytosolic D-Synuclein. 
Phosphorylation also occurs at S87, Y125, Y133 and Y135. This has been seen to 
implicate phosphorylated D-Synuclein in aggregate formation and to have led to more 
research into this modification. 
 Nt-acetylation has also been investigated, but with varying results. It has been 
UHSRUWHGWKDWµ1W-acetylation does not have prominent effects on the biophysical and 
membrane binding properties of D-Synuclein, in vitro and in vivo¶  Fauvet B et al. 
2012). But other papers have reported that Nt-acetylation can have an effect on            
D-helicity of the N-terminal, membrane interactions (Maltsev A.S. et al. 2012. Dikiy I. 
et al. 2014) and oligomer formation. (Trexler A.J. et al 2012). 
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1.5 N-terminal acetylation and use of NatB complex in E.coli 
 Amino terminal-acetylation is one of the most common protein modifications in 
eukaryotes, but is rarely seen in prokaryotes, occurring on approximately 84% of 
human proteins and 57% of yeast proteins. (Polevoda B. et al.2009). This is a co-
translational process in eukaryotes, but is post-translational in prokaryotes. It involves 
the transfer of an acetyl group from acetyl coenzyme A to the amino-terminal amino 
acid of a protein. This addition of an acetyl group to the                 N-terminal residue, 
neutralizes positive charges which can affect the stability and function of the protein 
DQGFRQVHTXHQWLDOO\LW¶VLQWHUDFWLRQVZLWKRWKHUSURWHLQVDQGPROHFXOHV 
 N-terminal acetylation is catalysed by a set of enzyme complexes, the N-terminal-D-
acetyltransferases (NATs). Six different NATs have been found in humans - NatA, 
NatB, NatC, NatD, NatE and NatF. Each of these different enzyme complexes is 
composed of a catalytic and an auxiliary subunit, and each is substrate specific for 
target amino-terminal amino acid sequences. The N-terminal amino acids of                  
D-Synuclein are Methionine and Aspartic acid, this sequence is acetylated by the NatB 
complex. 
 The NatB complex is composed of a catalytic subunit Naa20 and an auxiliary subunit 
Naa25, which are found in both yeast and humans but not in E.coli. NatB acetylates 
the N-terminal methionine of substrates starting with Met-Glu-, Met-Asp-, Met-Asn- or 
Met-Gln- N termini. 
 In vitro investigations into D-Synuclein have largely used recombinant protein 
produced and purified from E.coli.  As E.coli do not possess the NatB complex, the 
recombinant protein produced is un-acetylated and this may in turn have a significant 
effect on protein stability and interactions.   
 It is now possible to produce Nt-acetylated recombinant protein in E.coli. This is done 
by simultaneously expressing the recombinant protein with the NatB complex within 
E.coli. (Johnson M. et al. 2010). 
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1.6 Parkinson¶s Disease 
 3DUNLQVRQ¶V'LVHDVH3'LVDQHXURGHJHQHUDWLYHGLVorder, caused by the selective 
loss of dopaminergic neurones in the substantia nigra.  
 One person in every 500 has Parkinson's, about 127,000 people in the UK, 
3DUNLQVRQ¶V 8. DQG DQ HVWLPDWHG  WR  PLOOLRQ SHRSOH ZRUOGZLGH 3DUNLQVRQ¶V
Disease Foundation, Inc. USA). The main symptoms are tremor, slowness of 
movement (bradykinesia) and muscles stiffness (rigidity), though there are many other 
symptoms that can vary from person to person.  
 0RVWSHRSOHGLDJQRVHGZLWK3DUNLQVRQ¶VDUHRYHUZLWKLWEHLQJ most prevalent in 
people aged over 75, though a small number of people develop early onset or familial 
3DUNLQVRQ¶V7KHFDXVHRI3DUNLQVRQ¶VLVXQNQRZQDQGWKHUHLVQRFXUH 
 $GHILQLQJIHDWXUHRI3DUNLQVRQ¶VGLVHDVHLVWKHSUHVHQFHRI/HZ\%RGLHVF\WRSOasmic 
inclusions within the neurones of the substantia nigra, which consist mainly of                 
D-Synuclein. There is no consensus as to when D-Synuclein is most toxic in 
3DUNLQVRQ¶V GLVHDVH 6RPH EHOLHYH LW LV WKH VROXEOH SURWRILEULOV, oligomers with a            
E-sheet structure, that are the most toxic whereas others believe it is the matured 
aggregates (Winderickx J. et al 2008).The concentration of D-Synuclein within 
dopaminergic cells also seems to be linked to toxicity, as duplications and triplications 
RIWKH61&$JHQHDUHOLQNHGWRHDUO\RQVHW3DUNLQVRQ¶VGLVHDVH 
 Familial early onset ParkiQVRQ¶V disease has been linked to several missense 
mutations in and duplications and triplications of the SNCA gene that codes for             
D-Synuclein. (Kim W.S. et al 2014). Three of these have been the subject of several 
















 C-terminal truncations may also play a role in D-Synuclein aggregation, as truncated 
D-Synuclein has been found in Lewy bodies, from dementia with Lewy bodies brains 






N-terminal region                     
(residues 1-60) 
NAC region  
(residues 61 to 95) 
C-terminal region   
(residues 96 to140) 
A30P E46K H50Q G51D A53T 
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1.7 The use of S.pombe and E.coli as model organisms 
together with fluorescent microscopy. 
D-synuclein has been widely investigated in vitro and in vivo, using a variety of cell 
lines and model organisms, including mice, Drosophila melanogaster, Caenorhabditis 
elegans and Saccharomyces cerevisiae (Franssens V. et al 2013). 
 Model organisms such as these are all well understood, which are used to study 
human disease for a number of reasons, including ethical reasons, cost and time. A 
disease may take several years to develop in a human, but in an organism with a much 
shorter lifespan such as a mouse effects may be seen far more rapidly. Single celled 
organisms may not be complex enough to study age related diseases as a direct 
comparison, but have advantages in studying aspects of diseases such as protein 
interactions. Many model organisms such as S. cerevisiae, S. pombe and E.coli are 
frequently used due to their speed of growth, ease of use and the range of genetic 
tools that can be used with them. Due to their size, they can also be used for 
localisation studies using fluorescent microscopy. 
 Both S. cerevisiae and S. pombe, have a large number of key cellular processes that 
are well conserved between them and higher eukaryotes, including humans, though 
these do vary between the two types of yeast which are very different from each other. 
A large number of genes known to be involved in human diseases, have also been 
found to have a yeast orthologue, though this does not include the SNCA gene that 
codes for D-Synuclein. (Winderickx J. et al 2008). To study D-Synuclein in yeast, it is 
necessary to produce a humanised yeast strain by introducing the SNCA gene to 
produce D-Synuclein into the yeast, using genetic techniques. S. cerevisiae has been 
used extensively in the study of D-Synuclein, however there has been very little use of          
S. pombe.  
 S.pombe was first used as a model organism to study D-Synuclein, to investigate 
protein aggregation with both wild type and A30P, A53T and A30P/A53T mutant           
D-Synuclein, in this study no membrane binding was seen, as is seen in many studies 
using S. cerevisiae. Cytoplasmic aggregates were seen in cells producing wild type 
and A53T D-Synuclein (Brandis K.A. et al 2006).  
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 A second study using both S. cerevisiae and S.pombe to investigate wild type and 
A30P, A53T and E46K mutant D-synuclein, again also found that D-Synuclein did not 
bind to S.pombe plasma membranes, unlike in S. cerevisiae. However, this study 
found that when using a new strain of S.pombe the results were the same as in the 
first study, but with cytoplasmic aggregates also found with the E46K mutant. When 
this was repeated in the same strain as the first study, wild type, E46K and A53T D-
Synuclein was now seen to localise to endomembranes. (Fiske M. et al 2011). 
 Both of these studies show that S.pombe can be a useful model organism in 
investigations into D-Synuclein. The differences between the two studies highlight how 
the action of D-Synuclein may be very complex, with many unknown factors affecting 
its action, membrane binding and aggregation. It is also worth noting, that many of the 
cells in the figures of these papers have a very short appearance, possibly due to them 
being starved.  
 E.coli though often used as a model organism, does not appear to have been used 
as a model organism in its own right, in the study ofD-Synuclein. It has been used 
extensively in D-Synuclein studies to produce recombinant protein for purification and 
use in, in vitro investigations. However, it has not been possible to find any references 
to studies examining the effect of D-Synuclein on the E.coli that it is produced in. E.coli 
provides a very simple model system for gaining insight into mechanisms regulating 
protein membrane interactions. It has no internal membranes, only membranes at the 
periplasmic region which is in contrast to eukaryotic systems 
 Fluorescent microscopy is a powerful tool that can be used with both of these model 
systems. Fluorescent dyes that bind to specific structures, can be used to see the 
location of those structures within the cell. Genetic techniques can be used to join the 
gene for a fluorescent protein to the gene for the protein being studied, enabling the 
expression of the studied protein attached to a fluorescent protein, within live cells. 
This allows for the locations at which the studied protein localises to be seen. Different 
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1.8 The aim of this project 
 It was the aim of this project to investigate the membrane interactions, and oligomer 
and aggregate formation of D-Synuclein, and how these were affected by                       
Nt-acetylation, using both in vivo and in vitro techniques. This was carried out using 
two different model organisms, E.coli and S.pombe, to enable comparisons between 
both a prokaryotic and a eukaryotic model system. Firstly in S.pombe which is a good 
eukaryote model system used in the study of cell growth and the cell cycle. Secondly 
in E.coli, a commonly used prokaryote system. As E.coli would not normally be able 
to produce acetylated D-Synuclein, a strain producing the NatB complex was used to 
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2. CHAPTER II: MATERIALS AND METHODS 
 
2.1: Media recipes 
LB Medium (1 litre): 5g Yeast extract, 10g Tryptone, 10g Sodium Chloride, 15g Agar 
(if solid medium required) in 1 litre of distilled water. This was then autoclaved and if 
antibiotic selection was required 1Pl of the required antibiotic (Ampicillin at 50mg/ml in 
water or Chloramphenicol at 25mg/ml in Ethanol) per ml of medium was added after 
autoclaving. 
YES Medium (1 litre): 5g Yeast extract, 30g Glucose, 15g Agar (if solid medium 
required) in 1 litre of distilled water. 1 in 50 of Amino Acids are also added prior to 
autoclaving for liquid medium or just before pouring plates for solid medium. 
EMMG Medium (1 litre): 27.3g of Formedium EMM Broth (powder) w/o nitrogen, 
3.38g Glutamate, 15g Agar (if solid medium required) in 1 litre of distilled water. This 
was then autoclaved. 
50x Amino Acids (500ml): Uracil, Adenine, Histidine, Leucine. 5.625g of each amino 
acid is added to 500ml distilled water and then autoclaved. Each amino acid can be 
omitted as required to produce selective medium. 
 
 
2.2: Buffer recipes 
Phosphate Buffer Saline (PBS 1x): 8.7g Sodium Chloride, 1.82g Dipotassium 
hydrogenphosphate, 0.23g Potassium dihydrogenphosphate. In 1 litre of distilled 
water, adjusted to pH7.4 
20mMTris Buffer pH7.5: 12.11g Tris base in 5 litres of distilled water, adjusted to 
pH7.5.  
Buffer B: As used in protein purification 58.44g of Sodium Chloride is added to 1litre 
of 20mMTris buffer pH7.5. 
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Protein Loading Buffer: 50mM Tris-HCl pH6.8, 2%SDS, 10% Glycerol, 1%                   
E-mercaptoethanol, 12.5mM EDTA. 0.02%bromophenol blue. 
Western Blot Detection Buffer: 4ml of 1M Tris, 800Pl of 5M Sodium Chloride, 200Pl 
of 1M Magnesium Chloride, made up to 40ml with distilled water. 
Stop Buffer: 150mM Sodium Chloride, 10mM EDTA, 1mM Sodium Azide. 
IP (protein friendly) Buffer: 7.5ml distilled water, 600Pl of 3M Potassium Chloride, 
100Pl of 10%Triton, 1ml of 0.5M Hepes pH8, 100Pl of 0.5M EDTA pH8, 100Pl of 0.5M 
EGTA pH8, 500Pl of 1M Sodium 3 glycophosphate, 100Pl of PMSF (protease inhibitor 
added at the last moment).  
TAE Buffer: 0.4mM Tris base, 0.4mM glacial acetic acid, 0.01mM EDTA. 
 
2.3: Preparation of competent cells 
Strains of E.coli, either DH10E, BL21DE3, BL21Nat+A or BL21Nat+B were streaked 
out onto LB agar plates, containing the appropriate antibiotic if the cells possessed a 
plasmid and grown at 37oC overnight. From this a single colony was inoculated into 
5ml of LB medium with antibiotic where required and grown with shaking at 120rpm at 
37oC overnight. 0.5ml of this pre culture was then inoculated into 50ml of fresh LB 
medium with antibiotics as appropriate and grown with shaking at 120rpm at a 
temperature of 37oC until an OD600 of 0.6 to 0.8 was reached. The cells were then 
cooled on ice for 10 minutes, before being centrifuged at 3000rpm at 4oC for 10 
minutes. The pelleted cells were then resuspended in 10ml of ice cold 0.1M CaCl2 
(filter sterilised)/10%Glycerol solution and kept on ice for a further 15 minutes. The 
cells were then centrifuged again at 3000prm at 4oC for 10 minutes. The pelleted cells 
were then resuspended in 1ml of the 0.1M CaCl2/10%Glycerol solution and 40Pl 
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2.4: Bacterial transformation 
40Pl of competent bacterial cells were defrosted on ice, inoculated with an appropriate 
volume of DNA (1-10Pl), and were then kept on ice for 30 minutes. The cells were then 
heat shocked for 90 seconds at 42oC, and immediately transferred back onto ice for 2 
minutes. 100Pl of LB broth medium was then added and the cells incubated at 37oC 
for 1 hour. The cells were then plated out onto LB agar with appropriate antibiotics. 
 
 
2.5: Yeast transformation 
S.pombe were grown until a cell count of 106 cells per ml was reached. 20ml of the 
cells were then centrifuged at 3000rpm at 25oC for 5 minutes. The pelleted cells were 
then resuspended in 1ml of 0.1M Lithium Acetate pH4.7. The cells were then 
centrifuged again at 3000rpm at 25oC for 30 seconds. The pelleted cells were then 
resuspended in 0.1M Lithium Acetate pH4.7, 100Pl per transformation plus 100Pl for 
a No DNA control. The cells were then incubated at 25oC for 1 hour. 100Pl of 70% 
3(*ZDVWKHQSODFHGLQWRQHZ(SSHQGRUI¶VRQHIRUHDFKWUDQVIRUPDWLRQDQGWKH
No DNA control and 100Pl of the cells added to each tube, together with 3ml of the 
appropriate DNA where required. These were then vortexed to mix well and incubated 
at 25oC for an hour, vortexing every 20 minutes. The cells were then heat shocked at 
42oC for 10 minutes, 200Pl of EMMG was added and the cell incubated at 25oC for a 
further hour. The cells were then centrifuged for 1 minute at 3000rpm and 
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2.6: Small scale preparation of plasmid DNA from bacteria 
5ml of LB medium with appropriate antibiotic was inoculated with a single colony from 
a transformation plate and grown with shaking at 120rpm at 37oC overnight. This was 
then centrifuged at 3000rpm for 5 minutes and DNA preparation was then carried out 
using a Qiagen, Qiaprep Spin Miniprep Kit using the manufaFWXUHU¶V UHDJHQWVDQG
protocol. 
 
2.7: Restriction digests of DNA  
Restriction digests of DNA were carried out either for isolating DNA to subsequently 
be gel purified and ligated to form new constructs (large scale digests) or in order to 
check newly made clones had bands of the correct sizes when run on agarose gel 
(small scale digest). Different restriction enzymes were used depending on the 
restriction sites present, restriction enzymes used were manufactured by Promega 
and New England Biolabs and were used at the concentrations supplied. 
DNA was used where clear bands could be seen in an agarose gel, concentrations 
were not measured.  
A typical small scale digest consisted of: 
x 2Pl DNA 
x 2Pl 10x enzyme buffer 
x 14/15 Pl water 
x 1Pl Restriction enzyme 1  
x 1Pl Restriction enzyme 2 (if double digest required) 
 
A Typical large scale digestion consisted of: 
x 10Pl DNA 
x 10Pl 10x enzyme buffer 
x 76/78 Pl water 
x 2Pl Restriction enzyme 1  
x 2Pl Restriction enzyme 2 (if double digest required) 
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2.8: Cloning substrate genes into bacterial expression 
systems 
Ligations of purified insert fragments and vectors were typically carried out as follows: 
x 4Pl Insert DNA 
x 4Pl Vector 
x 1Pl 10x ligase buffer (Promega) 
x 1Pl T4 DNA ligase (Promega) 
 
PCR products were gel purified and ligated into the pGEM T-Easy vector. An example 
of this ligation reaction is: 
x 3Pl Purified PCR product 
x 1Pl pGEM T-Easy 
x 4Pl water 
x 1Pl 10x ligase buffer 
x 1Pl T4 DNA ligase 
All ligations were kept at 4oC overnight before use in bacterial transformations. 
 
 
2.9: DNA gel electrophoresis 
In order to check newly made clones or for isolating DNA to subsequently be gel 
purified, restriction digests of DNA were run on agarose gels. 1% agarose gels were 
made by dissolving 1g of agarose per 100ml of 0.5x TAE buffer. This was then heated 
until the solution was completely clear and poured into a casting tray, where 1Pl of 
Ethidium Bromide (10Pg/ml) per ml of 1% agarose gel was added. The DNA 
preparation was then run alongside 5Pl of Bioline Hyperladder at 50 Volts for 1 hour. 
DNA bands were then visualised under ultraviolet light. 
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2.10: Gel purification of DNA  
DNA from digests or PCR product was run on an agarose gel as described previously 





2.11: Polymerase Chain Reaction (PCR) 
PCR was used to amplify genes encoding for target proteins, allowing them to be 
cloned into bacterial expression systems. The primers used and their target genes are 
shown in Table.1. 
Primer Name Primer Sequence Target Gene 
Pci1cydABF ACatgttagatatagtcgaactgtcgcgc cydAB 
Sal1cydABR GTCGACgtacagagagtgggtgttacg cydAB 
Sal1mCherryF GTCGACatggtgagcaagggcgaggagg mCherry 
Not1mCHerryR gcggccgcTTActtgtacagctcgtccatgcc mCherry 
 
Table.1. Primers used for PCR during this project. 
 
2.12: Expression of recombinant proteins in E.coli and 
S.pombe. 
Expression of recombinant protein for live cell imaging and small scale protein 
analysis: Recombinant protein was expressed in both E.coli and S.pombe for live cell 
imaging.  
In S.pombe a pREP41 vector containing a repressible no message with thiamine (nmt) 
promoter upstream of the multiple cloning site (MCS) was used, so that recombinant 
protein expression was suppressed when thiamine was present in the medium used. 
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Cells were grown in 20ml of EMMG, either with (for very low levels to no expression) 
or without (moderate levels of expression) 1Pl per ml of 0.5mM thiamine. 
In E.coli, a T7 promoter was located on both the pETDuet and pJC20 plasmids used, 
this meant that recombinant protein was induced with the addition of 1Pl per ml of 
IPTG (0.1mg/ml stock). E.coli cells and the protein produced were examined at time 
points ranging from pre induction to 90 hours post induction. A single colony from a 
transformation plate was used, inoculated into 5ml of LB media with appropriate 
antibiotic and grown with shaking at 120rpm at 37oC overnight. 100Pl of this starter 
culture was used to inoculate 5ml of LB media with appropriate antibiotic and grown 
with shaking at 120rpm at 37oC until an OD600 of 0.4 to 0.6 was reached, 1Pl per ml of 
IPTG (0.1mg/ml stock) was then added to induce protein expression where required. 
Where cells were produced for protein analysis 1ml samples were taken, their OD600 
measured and then the cells centrifuged at 3000rpm for 5 minutes, pelleted cells were 
then stored at  -20oC until required. 
Expression of recombinant protein for Transmission Electron Microscopy (TEM) 
and large scale protein purification from growth media: Only E.coli was used for 
TEM and large scale protein purification from growth media. Again a single colony from 
a transformation plate was used, inoculated into 5ml of LB media with appropriate 
antibiotic and grown with shaking at 120rpm at 37oC overnight. 2ml of this starter 
culture was used to inoculate 200ml of LB media with appropriate antibiotic and grown 
with shaking at 120rpm at 37oC until an OD600 of 0.4 to 0.6 was reached, 1Pl per ml of 
IPTG (100mg/ml stock) was then added to induce protein expression. For TEM 
samples 50ml was then placed into a falcon tube and centrifuged at 2500rpm for 10 
minutes before being sent for preparation and examination by TEM.  
Cells induced for large scale protein purification from cell cleared culture media were 
grown and induced the same as for TEM, but the induced cells were grown for 4 days, 
before removal of cells from the culture media.  
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2.13: Purification of D-Synuclein by Fast Protein Liquid 
Chromatography (FPLC) 
The Protein samples expressed in E.coli and concentrated from the growth medium 
were purified by FPLC. The samples were run through a 5ml HiTrapQ ion exchange 
column and the bound protein was then eluted from the column using an increasing 
concentration gradient of Buffer B. Protein containing fractions were determined by 
absorbance at 260nm and 280nm. 
 
 
2.14: Preparation of cell extracts and media for protein 
analysis 
Different methods were used to prepare small scale protein samples for analysis. 
To prepare protein samples from S.pombe, cells were grown to a density of 106 
cells/ml. All preparation steps were carried out on ice or at 4oC. 10ml was then 
centrifuged at 3000rpm for 3 minutes. The pelleted cells were then resuspended in 
1ml of Stop Buffer and placed into a ribolyse tube. This was then centrifuged at 
13000rpm for 1 minute and the resultant pellet stored at -20oC. The pellets were then 
resuspended in 100Pl of IP (protein friendly) Buffer and 500Pl of glass beads were 
added. The cells were then broken by being placed in a fast prep ribolyse for 40 
seconds at 6.5. A hole was punched through the bottom of the tube and a further 100Pl 
of IP Buffer was added and the whole ribolyse tube placed into a 15ml falcon tube 
before being centrifuged at 3000rpm for 1 minute. The ribolyse tube was removed and 
the remaining supernatant and pellet resuspended and placed into an Eppendorf 
which was centrifuged at 13000rpm for 5 minutes. The resultant supernatant were 
retained for protein analysis and the pellet was resuspended in 200ml of IP Buffer to 
produce a further sample for protein analysis. 
To prepare whole cell protein samples from E.coli, a 1ml sample was taken from the 
cell suspension to be examined and its OD600 measured. The cells were then 
centrifuged at 3000rpm at 4oC for 5 minutes and the pelleted cells were frozen at              
-20oC. The defrosted pellet was then resuspended in 1xPBS Buffer according to the 
 21 | P a g e  
 
OD600 measured, e.g. a pellet from a culture with an original OD600 of 1.2 would be 
resuspended in 120Pl of 1xPBS.  
To prepare small scale protein samples for analysis, from cell cleared culture media, 
protein was precipitated from the media. A sample of E.coli cells growing in LB medium 
was centrifuged to remove all cells, 400Pl of the growth media was then placed to a 
2ml tube with 1.6ml of acetone and this was then frozen at -80oC. The thawed 
precipitated protein was then centrifuged at 13000rpm at 4oC for 30 minutes, the 
supernatant removed and the pellet dried. The pellet was then resuspended in 40Pl of 
1xPBS ready for analysis. 
To prepare protein samples for FPLC purification and analysis, from growth media, 
cells growing in 200ml of LB medium were centrifuged at 4600rpm for 10 minutes the 
supernatant was kept and the pelleted cells discarded. The supernatant was then 
centrifuged again at 4600rpm for 10 minutes. This supernatant was then placed into 
dialysis tubing which was placed into changes of 20mM Tris buffer pH7.5 at 4oC with 
stirring for 7 days. The supernatant was then filtered through a centricon centrifuge 
filter until concentrated to approximately 7ml ready for purification by FPLC. 
 
 
2.15: Gel electrophoresis of proteins 
Protein samples were analysed by gel electrophoresis using NuPAGE® Novex®          
4-12% Bis-Tris Gels from In vitrogen. Protein samples were mixed 4 parts sample to 
1 part 5x Protein loading buffer and heated at 95oC for 30 minutes with vortexing. 10Pl 
of each sample was run alongside 5Pl of Thermo Scientific PageRuler Unstained 
Protein Ladder #26614, at 150volts for 50 minutes, XVLQJWKHPDQXIDFWXUHU¶VUHDJHQWV
and protocol. Bands were visualised when required using Coomassie Blue 
(0.2%Coomassie blue, 7.5% Acetic acid, 50% Methanol) 
When gels were for use in Western Blotting, Bio-Rad Kaleidoscope Prestained 
Standards were used. 
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2.16: Western Blotting 
Gels were run as outlined above and protein transferred to a membrane using a Bio-
Rad Trans-Blot ElecWURSKRUHWLF7UDQVIHU&HOOIROORZLQJWKHPDQXIDFWXUHU¶VSURWRFROV
at 10volts for 30 minutes. The membrane was then blocked using Milk solution (1.5g 
milk powder in 50ml 1x PBS + 100Pl tween20) at room temperature for 1 hour. The 
membrane was then incubated in milk solution with primary antibody diluted 1 in 1000 
(anti-GFP or anti-a-Synuclein) at room temperature for 1 hour. The membrane was 
then rinsed four times in 1xPBS before having milk solution added until the membrane 
was just covered. 2Pl of secondary antibody (anti-mouse or anti-rabbit) added and this 
was incubated at room temperature for 1 hour. The membrane was then rinsed with 
1xPBS and then covered with fresh, Western Blot Detection Buffer for 5 minutes. 




2.17: Preparation of slides for fluorescent microscopy 
Lectin slides: During live-cell imaging, yeast cells were cultured in Edinburgh minimal 
media using 20 mM L-Glutamic acid as a nitrogen source (EMMG). Cells were grown 
exponentially at 25ºC for 48hr before being mounted (without centrifugation) onto 
lectin (Sigma L2380; 1 mg/ml) coated coverslip chambers 
PEI slides: PEI was diluted in distilled water and 10Pl placed onto a coverslip and 
allowed to dry for 1 minute. 10Pl of cells were then added and allowed to dry for 1 
minute. The coverslip was then fixed to the slide with double sided tape or nail varnish. 
This method was used with E.coli. 
Agarose slides: Agarose slides were used when E.coli had to be kept extremely still 
or for observing misshapen S.pombe, which did not stick well to lectin. A spacer slide 
was prepared by placing two bands of tape around a slide to form a lower space 
between the tapes.  2% agarose was then made in either distilled water or LB medium 
and heated until dissolved and appropriate antibiotic then added. LB medium was 
used when E.coli were incubated on the slide. 15Pl of hot liquid 2% agarose was then 
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placed onto the slide being made and the spacer slide placed quickly and firmly on 
top, so as to form a thin flat disc of agarose between the tapes. The spacer slide was 
then slid off leaving the agarose disc on the required slide. 10-15Pl of the cells to be 
viewed were then spread across the disc and allowed to dry until sticky, a coverslip 
was then placed on top and fixed to the slide with nail varnish. 
 
 
2.18: Obtaining fluorescent images of cells 
 Samples were visualised using an Olympus IX71 microscope with PlanApo 100x 
OTIRFM-SP 1.45 NA lens mounted on a PIFOC z-axis focus drive (Physik 
Instrumente, Karlsruhe, Germany), and illuminated using LED light sources (Cairn 
Research Ltd, Faversham, UK) with appropriate filters (Chroma, Bellows Falls, VT). 
An Optosplit device (Cairn Research Ltd) was used to allow simultaneous acquisition 
of signals from two fluorophores that emitted light of different wavelengths. Samples 
were visualised using either a QuantEM (Photometrics) EMCCD or Zyla 4.2 (Andor) 
CMOS camera, and the system was controlled with Metamorph software (Molecular 
Devices). Each 3D-maximum projection of volume data was calculated from 21 or 31 
z-plane images, each 0.2 µm apart, and analysed using Metamorph and Autoquant X 
software. 
Samples were fitted onto an ASI motorised stage (ASI, Eugene, OR) on the above 
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2.19: Obtaining images by Transmission Electron 
Microscopy (TEM) and Immuno EM 
E.coli cells were sent to Mr Ian Brown, Microscopy Suite Facility Manager, University 
of Kent, for preparation and thin sectioning to visualize the interior of the cells.  Three 
different preparation techniques were used including the use of, Osmium tetroxide and 
Thiocarbohydrazide, which strongly stains membranes, or using an immunogold-
staining technique post thin sectioning using 1 in 500 anti-D-Synuclein antibody and a 
secondary anti-rabbit antibody attached to 15nm gold discs. 
TEM: Preparation of samples for thin sectioning 
Cells were fixed for 2 hours in 1.5 ml 2.5 % Glutardialdehyde in PBS. Subsequently, 
the cells were pelleted and washed twice with PBS to remove traces of the fixing 
solution. The cells were stained for 1 hour in 1% osmium tetroxide and then washed 
twice with PBS before dehydration. This was accomplished by subjecting the samples 
to a solvent gradient: 70 % Ethanol for 20 minutes, 100 % Ethanol for 20 minutes, 100 
% Ethanol for 30 minutes, twice 100 % Propylene oxide for 30 minutes. The cells were 
embedded by first washing them in 50 : 50 Agar Low Viscosity Resin : propylene oxide 
for 60 minutes and then embedding them in 100 % Agar Low Viscosity Resin for 180 
minutes constituted for a block with medium hardness. The Samples were placed in 
0.5 ml embedding tubes, centrifuged for 5 minutes at 4,000 x g to concentrate the cells 
to the tip and incubated at 60ºC overnight to polymerise. 
  
Sectioning and visualisation of TEM samples 
Specimens were thin sectioned with glass knives on an RMC MT-6000-XL 
ultramicrotome, collected on formvar-coated copper grids, post-stained with 5% uranyl 
acetate for 30 minutes at 60ºC and 0.1% lead citrate for 10 minutes at room 
temperature. Sections were then observed and photographed with a JEOL-1230 
transmission electron microscope.  
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3. CHAPTER III: RESULTS; Schizosaccharomyces pombe        
3.1: Expression of D-Synuclein with a GFP tag 
It was first decided to ensure that human D-Synuclein could be expressed in S.pombe 
and that this could be observed by fluorescent microscopy, by means of a  Green 
Fluorescent Protein (GFP) fluorescent tag. A wild type S.pombe strain, h-Leu-32 
transformed with a pREP41 plasmid containing the gene for D-6\QXFOHLQIL[HGDWLWV¶
end to the cDNA for GFP. pREP41 contains a repressible no message with thiamine 
(nmt) promoter  upstream of the multiple cloning site (MCS), allowing expression levels 
to be modulated by the addition of thiamine. In this plasmid low levels of protein may 
still be produced when grown in the presence of thiamine. The same strain of S.pombe 
was also transformed using the same pREP41 plasmid containing only the GFP gene 
as a negative control. 
  Cultures of wild type S.pombe containing each vector, pREP41GFP (Figures 6 & 7) 
or pREP41 DS-GFP (Figures 8 & 9), were grown with thiamine to inhibit vector protein 
production and without thiamine to allow vector protein production, at 0.5PM in EMMG. 
All four cultures were mounted on slides using Lectin and observed using both phase 
and fluorescent microscopy. 
 
Figure.6. Image of S.pombe wild type pREP41GFP grown with thiamine, 
showing very low levels of cytoplasmic GFP.  





Figure.7. Images of S.pombe wild type pREP41GFP grown without thiamine, 
showing cytoplasmic GFP with some small aggregates. 
Figure.8. Images of S.pombe wild type pREP41DS-GFP grown with thiamine, 
showing cytoplasmic GFP, though this appears to be excluded from vacuoles, 
bright spots indicate the possible presence of small aggregates. 




Figure.9. Images of S.pombe wild type pREP41DS-GFP grown without thiamine, 
showing cytoplasmic GFP, which again appears to be excluded from vacuoles, 
bright spots indicate the possible presence of fewer larger aggregates. 
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3.2: Western Blot analysis of complete lysed cells 
    To confirm the presence and examine the levels of D-Synuclein-GFP produced, 
cultures of S.pombe wild type pREP41DS-GFP were grown with and without thiamine 
until stationary phase was reached, as confirmed by high cell counts. 
S.pombe wild type pREP41DS-GFP + thiamine   5.04x107 cells/ml 
S.pombe wild type pREP41DS-GFP - thiamine   4.64x107 cells/ml 
  10ml of each culture was prepared for analysis by Western Blot, keeping the cells 
and fractions on ice or at 4oC at all times during handling. During this first protein 
preparation TCA was used instead of IP (protein friendly) Buffer.  
  A Western Blot was then carried out on both samples using anti-GFP as the primary 
antibody and anti-mouse IgG as the secondary antibody (Figure. 10). D-Synuclein has 
an expected MW of 14.5kDa and GFP an expected MW of 26.9kDa. a-Synuclein-GFP 
is therefore expected to show a combined MW  of 41.4kDa. A dimer of D-Synuclein-
GFP would be expected to have a MW of 82.8kDa, a band is seen at about this weight 
in the sample grown without thiamine. 
 
Figure.10. Western Blot showing 
the presence of D-Synuclein-GFP 
as a monomer in the sample 
grown with thiamine where 
expression is at low levels and as 
both a monomer and possible 
dimer in the sample grown 
without thiamine, where 
expression is not inhibited and so 
at a higher level. 
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3.3: Growth Curves obtained at OD600 
  The four cultures of S.pombe wild type with pREP41GFP or pREP41DS-GFP grown 
both with and without thiamine were each prepared in EMMG to a density of 5x105 
cells/ml. 1ml of each was then placed into 4 wells of a 24 well plate. The plate was 
then placed into a plate reader set to shake the plate at 25oC and to take OD600 
readings every 30 minutes.  
 
  Figure.11. OD600 Growth Curves for S.pombe wild type containing pREP41GFP or 
pREP41DS-GFP. 
 The OD600 Growth Curves obtained (Figure. 11) show the two cultures with thiamine 
have the fastest rate of growth during log phase. The cells producing GFP showed a 
slightly slower growth rate possibly due to the production of GFP and the cells 
producing D-Synuclein-GFP show a much slower growth rate during log phase. The 
change in OD600 per hour was calculated for each culture during log phase (25 to 30 
hours) (Table.2). 
Time 25 30 Change per hour in OD600 
GFP +thi 0.913 1.476 0.112 
GFP -thi 0.737 1.223 0.097 
aS +thi 1.043 1.568 0.105 
aS -thi 0.458 0.801 0.068 
 
Table.2. Comparison of OD600 growth rates of S.pombe containing vectors 
pREP41GFP or pREP41DS-GFP grown with and without thiamine. 
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3.4: Western Blot Analysis of Separate Pellet and 
Supernatant fractions 
  Having seen evidence of D-Synuclein-GFP dimers in the first Western Blot it was 
decided to carry out another, using a gentler protein preparation method using protein 
friendly IP Buffer instead of TCA. It was also decided to look at where the D-Synuclein-
GFP was located within the cells by separate examination of the supernatant and 
pellet obtained following centrifugation of the lysed cells. This was carried out using 
cultures of S.pombe wild type with pREP41GFP or pREP41DS-GFP grown both with 
and without thiamine. 
  The Western Blot was carried out on all four samples using anti-GFP as the primary 




Figure.12. Western Blot which 
shows the presence of D-
Synuclein-GFP at the expected 
MW for a monomer in the sample 
grown with thiamine where 
expression is at low levels, but 
only in the supernatant. Bands of 
WKHH[SHFWHG0:¶VIRUERWK
monomer and dimer were seen in 
the supernatant of the sample 
grown without thiamine where 
expression is not inhibited and so 
at a higher level Possible 
damaged fragments of dimer 
were seen in both samples grown 
without thiamine. Dimer and dimer 
fragments only were seen in the 
pellet grown without thiamine. 
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  3.5: Cell length comparisons 
 It had been observed during Fluorescent microscopy that some of the S.pombe wild 
type with pREP41DS-GFP cells seemed to be longer than would be normal. To 
investigate whether there was any significant difference in cell length due to the 
presence of D-Synuclein-GFP and any possible effect on cell cycle and growth. 
Multiple images were taken of S.pombe wild type with pREP41GFP or pREP41DS-
GFP grown both with and without thiamine and their cell length measured in pixels on 
the computer. The average, maximum and minimum cell lengths were calculated for 











Total length 2858 3474 5044 2482 
No of cells 93 122 183 92 
Average length 30.7 28.4 27.5 26.9 
Maximum length 42.2 42.1 64.8 47.2 
Minimum length 18.5 14.0 14.6 17.0 
 
Table.3. Comparison of cell lengths in S.pombe wild type with pREP41GFP or 
pREP41DS-GFP grown both with and without thiamine, measured in pixels. 
 
  Although S.pombe wild type with pREP41DS-GFP was found to have a much larger 
maximum length, the average cell length was found to be midrange for the cultures 
examined.  
  
 32 | P a g e  
 
3.6: OD600 growth curves obtained for a naa25' S.pombe 
strain expressing D-Synuclein-GFP 
 To investigate whether N-terminal acetylation made any difference to the effects of   
D-Synuclein on cells, the same vectors as used earlier, pREP41GFP and pREP41DS-
GFP, where D-Synuclein is C terminally tagged with GFP, were transformed into a 
naa25' S.pombe strain. Naa25 encodes the auxiliary subunit of the fission yeast N-
D-acetyltransferase complex (NatB). This strain is unable to N-terminally acetylate D-
Synuclein. OD600 growth curves were obtained for each culture by repeating the 
procedure followed previously, but allowed to run for a longer time period due to the 




Figure.13. OD600 Growth Curves for a naa25' S.pombe strain containing 
pREP41GFP or pREP41DS-GFP grown with and without thiamine. 
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 The maximum rate of growth during log phase was calculated for each culture (Table. 
4). The two samples with thiamine showed the fastest growth rates. The pREP41GFP 
culture without thiamine, producing GFP, showed a slightly slower growth rate, 
possibly due to the production of the extra GFP protein. The pREP41DS-GFP culture 
without thiamine, producing D-Synuclein-GFP, showed a much slower growth rate, 
almost half that of the same culture grown with thiamine. The pREP41DS-GFP culture 
with thiamine also reached a higher overall OD600 the reason for this is unknown. 
 
 
Culture time points used 
OD600 at first time 
point 
OD600 at second 
time point Change per hour  
pREP41GFP +thia 45-55 0.583 1.100 0.0517 
pREP41GFP -thia 50-60 0.694 1.122 0.0428 
pREP41DS-GFP  +thi 45-55 0.744 1.267 0.0523 





Table.4. Comparison of OD600 growth rates of a naa25' S.pombe strain 
containing pREP41GFP or pREP41DS-GFP grown with and without thiamine.  
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3.7: Fluorescent Microscopy of a naa25' S.pombe strain 
expressing GFP or D-Synuclein-GFP 
  Fluorescent images were taken of the four naa25' S.pombe strain cultures used to 
obtain the previous growth curves (Figure 14), to compare the distribution of GFP 
andD-synuclein-GFP within S.pombe, when N-terminal acetylation of D-synuclein is 
not possible. As mentioned previously these naa25' cells are very slow growing, they 
also tend to grow in unusual deformed shapes and to clump together without any 
vectors having been transformed into them. 
Varying levels of fluorescence were also seen within each field of view this is possibly 
due to varying levels of plasmid uptake between cells. 
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Figure.14. Images of naa25' S.pombe containing pREP41GFP grown both with and without 
thiamine had a low levels of fluoresence. Bright spots indicate the presence of small aggregates 
that are excluded from the nuclei. Images of naa25' S.pombe containing pREP41DS-GFP grown 
with thiamine, have low levels of fluorescence indicating the presence of low levels of D-Synuclein-
GFP which appears to be dispersed through the cytoplasm but excluded from vacuoles. The image 
of naa25'S.pombe containing pREP41DS-GFP grown without thiamine, has higher levels of 
fluoresence indicating that a higher level of D-Synuclein-GFP was produced. This appears to be 
dispersed through the cytoplasm, but excluded from vacuoles in some cells. But in other cells bright 
spots indicate that the D-Synuclein-GFP may be starting to form small aggregates as with GFP alone. 
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3.8: The effect of acetylated and non-acetylated                  
D-Synuclein on growth at different temperatures 
 It was decided to undertake a separate short investigation into whether the presence 
of either acetylated or non-acetylated D-Synuclein had any effect on growth at different 
temperatures. 
  Six plates were quartered and three had thiamine added to them. Each quarter was 
streaked with one of the four following colonies. S.pombe wild type pREP41GFP, 
S.pombe wild type pREP41DS-GFP, naa25'S.pombe pREP41GFP and 
naa25'S.pombe containing pREP41DS-GFP.One plate with and one without 
thiamine were incubated together at 25oC, 28oC and 35.5oC. The growth was recorded 
(Table. 5) and pictures taken. Unfortunately due to computer problems the pictures 





pREP41GFP pREP41DS-GFP pREP41GFP pREP41DS-GFP 
25oC wild type lots of growth lots of growth lots of growth lots of growth 
naa25' lots of growth lots of growth lots of growth lots of growth 
28oC wild type lots of growth moderate growth lots of growth moderate growth 
naa25' moderate growth moderate growth low growth moderate growth 
35.5oC wild type lots of growth lots of growth lots of growth lots of growth 






 pREP41GFP pREP41DS-GFP pREP41GFP pREP41DS-GFP 
25oC wild type lots of growth lots of growth lots of growth lots of growth 
naa25' lots of growth lots of growth lots of growth lots of growth 
28oC wild type lots of growth lots of growth lots of growth lots of growth 
naa25' lots of growth lots of growth lots of growth lots of growth 
35.5oC wild type lots of growth lots of growth lots of growth lots of growth 
naa25' no growth very low growth no  growth very low  growth 
 
Table.5. Comparison of observed growth of S.pombe producing acetylated and 
unacetylated D-Synuclein at different temperatures. 
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3.9: Western Blot analysis of Separate Pellet and 
Supernatant fractions from a naa25' strain 
To investigate whether N-terminal acetylation of D-Synuclein causes any differences 
in where the D-synuclein-GFP is located within S.pombe cells a Western Blot was 
again carried out with separate examination of the supernatant and pellet obtained 
following centrifugation of the lysed cells, as previously carried out with Wild type 
S.pombe pREP41DS-GFP. This was carried out using cultures of a naa25' S.pombe 
strain containing pREP41DS-GFP grown both with and without thiamine. The naa25 
deletion means that the cells are unable to produce the naa25 auxiliary subunit of the 
NatB complex and so is unable to acetylate D-Synuclein. This is shown alongside the 
previous Western blot for comparison (Figure 15). 
Again bands were seen at the approximate MW expected to be seen for monomers 
(41.4kDa) and dimers (82.8kDa) Bands were also seen again between these weights 
possibly of damaged dimer fragments. 
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Figure.15. Western Blots that compare the presence of D-Synuclein-GFP as a 
monomer in the samples grown with thiamine, but seen only in the supernatant. 
Both monomer, dimer and fragments of dimer were seen in both of the ±thiamine 
supernatants where expression is not inhibited and so at a higher level. Clear bands 
were only seen at the weight expected for dimers in both of the ±thiamine pellets, 
faint bands were also visible also slightly below this weight possibly due to 
damaged dimer fragments. 
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3.10: Fluorescent Microscopy to show D-Synuclein 
Distribution Using Cerulean3 Fluorescent Protein 
 In an attempt to improve the resolution of the images taken and for use in combination 
with other fluorescent proteins, a new vector was produced replacing the cDNA for 
GFP with the cDNA for Cerulean3 Fluorescent Protein (Cer3) which is a brighter more 
stable protein. Wild type S.pombe cells containing pREP41DS-Cerulean3 were grown 
with and without thiamine. Slides were then prepared using Lectin and the cells 
observed and images taken using fluorescent and phase microscopy (Figures 16 & 
17). 
Cerulean3          Phase     . 
 
 
Figure.16. Images of wild type S.pombe pREP41DS-Cerulean3 grown with 
thiamine to repress vector expression. At low levels of vector protein expression 
very little fluorescence could be observed and so produced only faint fluorescent 
images, where the fluoresence appears to be cytoplasmic. Phase images were 
included to clearly show the cells being observed. 
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Figure.17. Images of wild type S.pombe pREP41DS-Cerulean3 grown without 
thiamine. At higher levels of vector protein expression far more fluorescence could 
be detected. In some cells with slightly lower levels this appears to be cytoplasmic, 
with a slight concentration at the poles. In others with higher levels it appears to be 
excluded from vacuoles and concentrated at the separation membrane. 
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3.11: Fluorescent Microscopy to show D-Synuclein 
Distribution in Relation to Membranes 
To compare the distribution of D-Synuclein with the presence of membranes, wild type 
S.pombe pREP41DS-Cerulean3 were grown again with and without thiamine. A 1ml 
sample of each culture was stained with 1Pl of FM4-64, a lipophilic probe which 
fluoresces red when it associates with plasma membranes. Slides were then prepared 
using Lectin and the cells observed and images taken using fluorescent and phase 
microscopy (Figures. 18 & 19) using appropriate filters and Light Emitting Diodes for 
the aquisition of images of Cerulean3 and Red fluorescent protein. 




Figure.18. Images of wild type S.pombe pREP41DS-Cerulean3 grown with 
thiamine. Again low levels of vector protein expression led to very little fluorescence 
being detected in comparison to the images of induced cells. The fluorescence 
observed still appears to be cytoplasmic but in one cell did seem to be concentrated 
at the separation membrane (red arrow). The FM4-64 did not stain all of the cells 
clearly but some have clearly stained vacuole membranes. 
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Cerulean3                    FM4-64                      Phase 
 
   
 
 
Figure.19. Images of. wild type S.pombe pREP41DS-Cerulean3 grown without 
thiamine Again higher levels of vector protein expression led to far more 
fluorescence being detected. In some cells with slightly lower levels this appears to 
be more cytoplasmic. In others with higher levels it appears to be excluded from 
vacuoles but present within the nucleus and concentrated at the separation 
membrane. Two cells appear to have aggregates on the membrane (red arrows). 
The FM4-64 did not stain all of the cells clearly but some have clearly stained 
vacuole membranes and is excluded from the nucleus. 
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3.12: Fluorescent Microscopy of S.pombe with     
pINT41DS-Cerulean3 integrated into its genome 
To avoid the varying levels of recombinant protein expression seen, when using the 
pREP41 vector, due to varying levels of plasmid uptake between cells, a pINT41 
vector was used to integrate a single copy of the recombinant DNA for D-Synuclein-
Cerulean3 into the genome of a wild type S.pombe strain with the ability to integrate 
the pINT vector into its genome. This was integrated into the Leucine gene disrupting 
it and introduced a new Uracil gene. Cells with the correctly integrated gene were 
selected as they were able to grow on EMMG + amino acids ±Uracil + thiamine, but 
could no longer grow on EMMG + amino acids ±Leucine + thiamine.  
The Integration of a single copy of the vector into the genome enables the cells to 
produce a consistent level of D-Synuclein-Cerulean3 which should negate any effects 
due to large variations of D-Synuclein-Cerulean3 concentration within the cells of each 
culture. Different promoters could also be used in the future to more accurately 
compare the effect of different concentrations of D-Synuclein-Cerlean3 on cells. 
Levels of expression of the integrated recombinant protein were very low both with 
and without the presence of thiamine. However it was apparent that the levels 
expressed were sufficient to have a large effect on the cell phenotype. Cells were 
stained with FM4-64 to see more clearly how plasma membranes were being affected 
within these cells. Images were taken of cells grown for 1 (Figures 20 & 21) and 2 days 
(Figures 22 & 23) with and without thiamine. 
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Figure.20. Images of S.pombe pINT41DS-Cerulean3, grown for 1 day with thiamine, 
stained with FM4-64. At the very low levels of vector protein expression created by a 
single copy of the integrated DS-Cer3 vector in the presence of thiamine only 
extremely low levels of fluorescence could be detected. Despite using image 
enhancement only very faint cerulean images could be produced. The images 
obtained using FM4-64 dye  and phase images show very misshapen cells, some of 
which also show multiple septa (red arrows), very thick septa (blue arrow) and unusual 
shaped vacuoles (green arrow). 
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Figure.21. Images of S.pombe pINT41DS-Cerulean3, grown for 1 day without 
thiamine, stained with FM4-64. At the higher levels of vector protein expression 
created by a single copy of the integrated DS-Cer3 vector without thiamine, compared 
to growth with thiamine, very low levels of fluorescence could still only be detected. 
Despite using image enhancement only very faint cerulean images could be produced. 
The images obtained using FM4-64 dye and phase images show very misshapen 
cells, some of which also show multiple septa (red arrows) and unusually large 
vacuoles (green arrow). 
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Figure.22. Images of S.pombe pINT41DS-Cerulean3, grown for 2 days with thiamine, 
stained with FM4-64. After 2 days of growth with thiamine very low levels of vector 
protein expression created by a single copy of the integrated DS-Cer3 vector, meant 
that only extremely low levels of fluorescence could be detected. Despite using image 
enhancement only very faint cerulean images could be produced. The images 
obtained using FM4-64 dye  and phase images show very misshapen cells, some of 
which also show multiple septa (red arrows) and very thick septa (blue arrow). Cell 
vacuoles can no longer be clearly seen. 
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Figure.23. Images of S.pombe pINT41DS-Cerulean3, grown for 2 days without 
thiamine, stained with FM4-64. After 2 days growth without thiamine the higher levels 
of vector protein expression, compared to cells grown with thiamine, created by a 
single copy of the integrated DS-Cer3 vector, created only low levels of fluorescence. 
Despite using image enhancement only very faint cerulean images could be 
produced. The images obtained using FM4-64 dye and phase images show very 
misshapen cells, some of which also show multiple septa (red arrows) and very thick 
septa (blue arrow). Vacuoles can only be seen clearly in a few cells (green arrow). 
Some cells also appear to be producing bleb like structures (white arrows). 
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3.13: Examination of numbers of septa seen in wild type 
S.pombe with and without pINT41DS-Cerulean3 integrated 
into its genome 
 
 Cells with pINT41aS-Cerulea3 integrated into their genome appeared to be having 
difficulty completing their cell cycle, producing septum but then being unable to 
complete division into two daughter cells, resulting in cells with multiple septa. Due to 
the large number of cells with multiple septa seen in wild type S.pombe with 
pINT41DS-Cerulean3 integrated into its genome, it was decided to compare cells 
grown both with and without the integrated gene. Cells were grown in EMMG, both 
with and without thiamine and images taken of 20 fields of view, after 1 and 2 days 
incubation at 25oC with shaking. Cells within each field were counted according to the 
number of septa within the cells and the percentage of cells with each number of septa 
was calculated (Table.6).  
 
No of Septa 0 1 2 3 Total 
No. Of 
cells 
WT S.pombe, No vector   . 





  107 









WT S.pombe, No vector.    








WT S.pombe, No vector.  





  145 
WT S.pombe pINT41DS-














































Table.6. Septa in wild type S.pombe with and without pINT41DS-Cerulean3 integrated 
into its genome at 1 and 2 days, grown in the presence and absence of thiamine. 
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4. CHAPTER IV: RESULTS; Escherichia coli      
4.1: Expression of D-Synuclein in E.coli 
It was decided to investigate the effect of D-Synuclein upon the physiology of the 
bacteria Escherichia coli (E.coli). E.coli BL21 DE3 cells were transformed using, a 
pJC20 vector containing the gene for D-Synuclein fused to cDNA encoding the 
Cerulean3 protein. A broth culture was then induced to produce this protein by the 
addition of IPTG to a concentration of 0.1mg/ml. Comparison of pre and 2 hours post 
induction cell extracts (Figure. 24) indicates the induced expression of the fusion 
protein which migrated at the predicted size of 42.2kDa.  
 
Figure.24 Coomassie stained gel, the two post induction protein samples on the 
right, show a large increase in protein produced, compared with pre induction. 
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4.2: Fluorescent microscopy of D-Synuclein in E.coli with 
and without acetylation 
  Fluorescent microscopy was used to examine E.coli cells expressing D-Synuclein-
Cerulean3. It was also decided to examine a second culture produced by transforming 
the same vector pJC20 D-Synuclein-Cerulean3 into E.coli BL21+NatB cells. These 
E.coli contain a plasmid expressing the N-terminal acetyltransferase B (NatB) 
complex, (Johnson M. et al. 2010) that facilitates the N-terminal acetylation of the,        
D-Synuclein, produced within the cell. 
  Expression of recombinant protein was induced with IPTG, slides were prepared and 
images taken at Pre induction and at 1, 2 and 3 hours post induction (Figure 25).  
   Due to the unusual appearance of these cells, it was decided to further investigate 
the effects of D-Synuclein in E.coli at higher resolution using negative stain Electron 
Microscopy. 
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Figure.25. (Following page) Images of BL21DE3 DS-Cerulean3 cells and 
BL21+NatBDS-Cerulean3 cells, Pre induction and 1, 2 and 3 hours post 
induction. BL21DE3 DS-Cerulean3 cells show only low levels of fluorescence, 
which appeared to be cytoplasmic. In the image taken at 1 hour post induction, 
more fluorescence was seen, this still appeared to be predominantly cytoplasmic, 
but some brighter areas appeared to show the start of some localisation and 
possible aggregate formation. In the image taken at 2 hours post induction. Some 
fluorescence still appeared to be cytoplasmic. However, some cells appeared to 
have bright concentrations of fluorescence, possibly indicating the presence of 
aggregates or blebbing around the outside of the cells. Other cells appeared to 
have ribbon like areas of localisation, predominantly but not exclusively, on the 
inside of the plasma membrane. In the image taken at 3 hours post induction, 
there was a complete mix of appearances. Some cells still appeared to have 
cytoplasmic Cerulean3. Some have areas of bright fluorescence or possible 
aggregates or blebbing around the outside of the cell. Some have ribbon like 
concentrations within the cell and some have a mixture of these appearances. 
This variation may be due to differing concentrations of plasmid present in different 
cells. 
It was not possible to take images of BL21+NatBDS-Cerulean3 cells, Pre 
induction, as the level of fluorescence was too low. In the image of BL21+NatBDS-
Cerulean3 cells taken at 1 hour post induction. Fluorescence appeared to be 
mainly cytoplasmic. A few cells have areas that seem to have a slightly higher 
level of fluorescence. The images of BL21+NatBDS-Cerulean3 cells, taken at 2 
hours post induction show lots of blebbing around some cells together with some 
of the ribbon like localisation. In the images of BL21+NatBDS-Cerulean3 cells, 
taken at 3 hours induction, only a few blebs or aggregates were visible on the 
outside of the cells. However the ribbon like localisation was seen to be more 
dominant and more clearly defined.   (Scale-1Pm) 
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4.3: Electron microscopy of D-Synuclein in E.coli with and 
without acetylation 
  The two cultures observed by fluorescent microscopy were observed using 
Transmission Electron Microscopy (TEM). 50ml cultures were induced during log 
phase using IPTG for 2 hours, they were then spun at 2500rpm for 10 minutes to 
produce a pellet that was sent for preparation and observation by TEM. 
 
 
Figure.26. Images of slices of thin sectioned BL21DE3 DS-Cerulean3 cells taken at 
2 hours induction using TEM. The TEM images show clear blebbing on the outside 
of the cells producing unacetylated D-Synuclein-Cerulean3. The blebs appear to be 
membrane bound structures being released from the cell surface. 




Figure.27. Images of slices of thin sectioned BL21+NatBDS-Cerulean3 cells 
producing acetylated D-Synuclein-Cerulean3 were seen to be producing lots of 
smaller blebs. They were also seen to be producing structures with a tubular 
network. These seemed to originate on the inside of the plasma membrane and 
build up into the inside of the cell. Some cells appear to be having difficulty dividing, 
possibly due to the presence of these structures (see arrow on third image). These 
structures seem to be what creates the ribbon like appearance seen in the 3 hour 
fluorescent microscopy. 
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4.4: Electron microscopy of N-terminally acetylated           
D-Synuclein in E.coli using an enhanced membrane 
preparation. 
  It was decided to examine BL21+NatBDS-Cerulean3 cells by TEM, using a treatment 
to enhance membrane staining, with Osmium tetroxide and Thiocarbohydrazide 
(Figure.28). The structures with a tubular network could be seen more clearly, blebbing 
around cells and some cells appearing to have separation defects (see arrows on third 
image), could also be observed. This data is consistent with these structures having 
significant membrane components. 
  
  
Figure.28. 4 TEM images of BL21+NatBDS-Cerulean3 cells, using a darker 
Osmium tetroxide and Thiocarbohydrazide stain, to enhance the appearance of the 
internal tubular structures. Red arrows indicate cells that appear to be having 
difficulty dividing. 
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4.5: Anti D-Synuclein Immuno E.M. 
  An immunogold-staining technique was employed to confirm the location of                  
D-Synuclein within the cells, to confirm whether it was associated with the D-Synuclein 
induced structures. Cultures of BL21+NatADS-Cerulean3, an E.coli producing             
N-terminal acetyltransferase A (NatA), which does not N-terminally acetylate                 
D-Synuclein, BL21+NatB DS-Cerulean3, producing acetylated D-Synuclein and a 
control of BL21+NatB containing an empty vector, which does not produce D-
Synuclein, were examined at 2hours 30 minutes post induction. BL21+NatA                
DS-Cerulean was used to produce unacetylated D-Synuclein as it is a more directly 
comparable control to the BL21+NatB DS-Cerulean, as both cell types are producing 
additional acetylation complexes. During their preparation the cells were treated with 
a primary antibody, Rabbit polyclonal anti D-Synuclein antibody (abcam ab155038) 
and then a secondary anti rabbit antibody attached to 15nm gold discs that appear as 
black spots on the images.  
  The tubular networks are not seen as clearly as in the initial TEM images, as 
H[SHFWHG GXH WR WKH GLIIHUHQW SUHSDUDWLRQ WHFKQLTXH 7KH EODFN ³JROG ODEHO´ VSRWV
indicate the presence and location of D-Synuclein (Figures.30 & 31) and an absence 
of EODFN³JROGODEHO´VSRWVLQGLFDWHs an absence of D-Synuclein (Figure 29). They do 
not show the exact location due to the length of the two antibodies joined together 
which separate the gold disc and the D-Synuclein protein that they connect to, which 
can be 15 to 30nm. 
  
Figure.29. Image of BL21+NatB cells containing an empty vector. No immuno 
staining could be seen indicating an absence of D-Synuclein. 





Figure.30. Image of BL21+NatADS-Cerulean3 cells, showing immuno staining to 
be concentrated in the areas where the tubular networks were seen in earlier 
images, in the areas inside the plasma membrane 
Figure.31. Image of BL21+NatBDS-Cerulean3 cells showing immuno staining, 
which again appears to be concentrated in the areas where the tubular networks 
were seen previously. 
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4.6: Growth curves obtained at OD600. 
  OD600 growth curves were generated for the E.coli, BL21NatBDS-Cerulean3 cells, 
BL21+NatB cells containing an empty vector and BL21+NatADS-Cerulean3 cells, 
used in the previous microscopy. A second control BL21+NatA cells containing an 
empty vector, was also included. This enabled a direct comparison of cells producing              
D-Synuclein-Cerulean3 or containing an empty vector and both types of cells with and 
without the ability to Nt-acetylate D-Synuclein. Growth curves were obtained for each 
of the four cultures, both with and without the addition of IPTG, to induce vector protein 
production. The cultures were shaken at a temperature of 37oC with readings taken 
every 15minutes. Rates of growth were compared by calculating the change in OD600 





Figure.32. Graph to compare growth rates, of acetylated and unacetylated         
D-Synuclein and an empty vector using OD600. 
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  Table.7. The rate of growth during log phase, calculated for each culture. For both 
empty vectors and the unacetylated D-Synuclein the rates were fairly similar. The rate 
with acetylated D-Synuclein was almost half of that for the other samples.  
 
Sample Time points 
used 
Tp 1 Tp2 Rate-OD600 change/hour 
BL21 DE3 NatA empty vector 
uninduced 
23-27 0.641 1.035 0.098 
BL21 DE3 NatA  empty vector 
induced 
23-27 0.639 1.041 0.100 
BL21 DE3 NatB empty vector 
uninduced  
23-30 0.549 1.088 0.077 
BL21 DE3 NatB empty vector 
induced  
23-30 0.519 1.156 0.091 
BL21 DE3 NatA  DS-Cer3 
uninduced  
23-30 0.837 1.434 0.085 
BL21 DE3 NatA  DS-Cer3 
induced 
23-30 0.797 1.363 0.080 
BL21 DE3 NatB DS-Cer3  
uninduced 
23-37 0.437 1.097 0.047 
BL21 DE3 NatB  DS-Cer3 
induced 
23-37 0.531 1.267 0.052 
 
 
Unexpectedly the uninduced BL21 DE3 NatB appears to inhibit growth the most, 
however at a difference of 0.005 change on OD600 per hour this is within the 
sensitivity of the test  
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4.7: Comparison of Acetylated and Unacetylated                 
D-Synuclein produced in E.coli. 
 To compare the D-Synuclein protein produced in BL21+NatADS-Cerulean3 cells and 
BL21NatBDS-Cerulean3 cells, cell extracts both pre induction and 21/4 hours post 
induction, were examined. Cells were sonicated and supernatant and pellet fractions 
were separated and run on 4-12% Bis-Tris Gels, which were analysed by either 
Coomassie stain or anti D-Synuclein Western Blot (Figure 33). This shows that 
unacetylatedD-Synuclein was only found in the supernatant. It also shows that 
acetylated D-Synuclein is found as a monomer in the supernatant, but that it was 
present mostly as oligomers. Acetylated D-Synuclein was also found in the pellet as 
well, as an oligomer. 
 
 Figure.33. Coomassie stained 4-12% Bis-Tris gel and western blot of 
BL21+NatADS-Cerulean3 cells and BL21NatBDS-Cerulean3 cell extracts. 
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4.8: Fluorescence growth curves of E.coli cells expressing 
D-Synuclein-Cerulean3 
 To compare the level of toxicity, of acetylated versus unacetylated D-Synuclein-
Cerulean3 in the E.coli cells in which they were expressed (Figure 41), together with 
the levels of D-Synuclein-Cerulean3 produced in the E.coli cells, as measured by 
fluorescence (Figure 34). BL21+NatADS-Cerulean3 cells and BL21NatBDS-
Cerulean3 cells were grown both in a fluorescent plate reader, with and without the 
addition of IPTG, to induce vector protein production. The cultures were shaken at a 
temperature of 37oC with readings taken every 15minutes.  
Fluorescence was seen at lower levels in the uninduced controls due to the T7 
promoter allowing low levels of protein production in the absence of IPTG. The reason 
for the biphasic increase in fluorescence is not known, but was noticed to have 
occurred shortly after stationary phase was reached. 
 
Figure.34. Fluorescent growth curve comparing BL21+NatA DS-Cer3 and BL21+NatB 
DS-Cer3 cells producing acetylated and unacetylated D-Synuclein-Cerulean3, grown 
with and without the addition of IPTG  
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 Unexpectedly the acetylated D-Synuclein-Creulean3, which appeared to be the most 
toxic form to cells when measured by OD600, produced a lower initial level of 
fluorescence compared to the unacetylated D-Synuclein-Creulean3. However at 50 
hours, when according to the OD600 readings the cells were in stationary phase, the 
level D-Synuclein-Creulean3 of fluorescence began to increase again until it reached 
the same value as that obtained for the unacetylated.  Due to these unexpected 
results, it was decided to further examine these two cultures together with controls 
producing just GFP and D-Synuclein without a fluorescent marker (a vector obtained 
from outside of this University), at 24 and 90 hours post induction, by fluorescent 
microscopy, TEM and immuno EM. 
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4.9: Fluorescent microscopy of BL21+NatB S-Cerulean3 
and BL21NatB-GFP staining with FM4-64 
It was decided to look at the BL21+NatBDS-Cerulean3 culture used previously, 
together with E.coli expressing NatB and GFP, with FM4-64 stain (Figures 35 & 36).  
 
Phase                                    FM4-64                                 Cerulean3 
 
 
Figure.35. Images of BL21+NatBDS-Cerulean3 cells, stained with FM4-64. Blebs 
can be seen in the Cerulean3 images (Red arrows) (Scale 1Pm). 
 
Phase                               FM4-64                          GFP 
 
 
Figure.36. Images of BL21+NatB-GFP cells, stained with FM4-64 (Scale 1Pm). 
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4.10: Simultaneous analysis of BL21+NatA S-Cerulean3, 
BL21+NatB S-Cerulean3, BL21+NatA S, BL21+NatB S 
and BL21+NatB GFP, using Fluorescent Microscopy, TEM, 
Immunogold TEM and protein analysis. 
  Due to the unexpected fluorescent curves obtained, it was decided to complete a 
large scale comparison of E.coli producing both acetylated and unacetylated                  
D-Synuclein, both with and without a fluorescent protein marker, together with a control 
producing NatB and GFP. Previously growth curves had shown that acetylated                      
D-Synuclein-Cerulean3, appeared to be more toxic to cells than unacetylated                
D-Synuclein-Cerulean3 when measured by OD600, yet produced a lower initial level of 
fluorescence and possibly correlating lower level of D-Synuclein-Cerulean3, compared 
to the unacetylated D-Synuclein-Cerulean3. However at 50 hours, when according to 
the OD600 readings the BL21+NatBDS-Cerulean3 cells were in stationary phase, the 
level of fluorescence began to increase again until it reached the same value as that 
obtained for the unacetylated. 
 This raised several questions. Were lower levels of acetylated D-Synuclein- 
Cerulean3 really being produced, was acetylated D-Synuclein-Cerulean3 more toxic 
than the unacetylated, or was something else causing these results and would it be 
possible to see differences by microscopic examination.  
 In an attempt to answer these questions the five different cultures were compared 
using Fluorescent Microscopy, TEM, anti D-Synuclein Immunogold TEM and protein 
analysis at 24 and 90 hours post induction. 
  When the cultures were centrifuged to be sent for preparation for TEM and Immuno 
EM, The 24hour samples producing DS-Cer3 and GFP produced pellets that could be 
clearly seen to be fluorescent. The 90 hour samples showed no signs of fluorescence 
and were thought not to have been induced correctly. All of the 90 hour samples were 
discarded and prepared again. 
  The second set of 90 hour samples were set up and observed by fluorescent 
microscopy at 1 hour post induction to confirm that DS-Cer3 and GFP were being 
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produced in the appropriate cultures. After 90 hours the samples were centrifuged to 
produce pellets for preparation for observation by TEM and ImmunoEM. Again the 
pellets showed no sign of fluorescence, however as induction had been confirmed by 
the post induction fluorescent microscopy, the cell cleared culture media were kept for 
examination by fluorescent spectrometry (Figure 37). Protein samples were also 
prepared for analysis, by precipitating protein from the cell cleared culture medium. 
For each 90 hour culture, 400Pl of supernatant was added to 1.6ml of acetone, to 




Black ± BL21+NatA DS-Cerulean3     Purple ± BL21+NatA DS      Red ± BL21+NatB GFP              
Blue ±  BL21+NatB  DS-Cerulean3    Brown ± BL21+NatB DS 
 
Figure.37. Fluorescent scans of cell cleared culture medium, from cultures of 
BL21+NatA DS-Cer3, BL21+NatA DS, BL21+NatB GFP, BL21+NatB DS-Cer3 and   
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 Shoulders were seen in the fluorescent scans, close to the maximum emission 
wavelengths for Cerulean3 at 475nm and GFP at 508nm, this indicates the presence 
of Fluorescent Proteins in the 90 hour post induction cell cleared culture medium. The 
release of proteins into the cell cleared culture medium, explains the lack of 
fluorescence within the pellets. 
 Cells from all five cultures were stained with FM4-64 and examined by phase and 
appropriate fluorescent microscopy and images taken. Images were also taken using 
TEM and Immuno EM (Figures 38 to 42). The Immuno EM results were not as 
expected. 7KHEODFN³JROGODEHO´VSRWV present in the BL21+NatADS-Cerulean3 and 
BL21+NatBDS-Cerulean3 cells indicate the presence and location of D-Synuclein 
within them as expected (Figures.38 & 39). However DQDEVHQFHRIEODFN³JROGODEHO´
spots in the BL21+NatADS, BL21+NatBDS and BL21+NatB GFP cells (Figures 40 to 
41) indicates an absence of D-Synuclein, when it was expected to be present in the 
first two of these cells. In the TEM images some cells again appear to have separation 
defects (see red arrows). The cells producing D-Synuclein alone were very difficult to 
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Figure.38. Images of BL21+NatADS-Cerulean3 cells 24 hours Post Induction, 
obtained using Phase and Fluorescent light microscopy (stained with FM4-64. Scale 
1Pm), TEM and Immuno EM. 
Cerulean3             FM4-64                  Phase       . 
 
TEM                               
  
 Immuno EM 
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Figure.39. Images of BL21+NatBDS-Cerulean3 cells 24 hours Post Induction, 
obtained using Phase and Fluorescent light microscopy (stained with FM4-64. Scale 
1Pm), TEM and Immuno EM. Red arrows indicate cells that appear to be having 
difficulty dividing. 
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Figure.40. Images of BL21+NatADS cells 24 hours Post Induction, obtained using 
Phase and Fluorescent light microscopy (stained with FM4-64. Scale 1Pm), TEM and       
Immuno EM. 
FM464                 Phase 
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Figure.41. Images of BL21+NatBDS cells 24 hours Post Induction, obtained using 
Phase and Fluorescent light microscopy (stained with FM4-64. Scale 1Pm), TEM and        
Immuno EM. Red arrows indicate cells that appear to be having difficulty dividing. 
FM4-64                                                    Phase 
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Figure.42. Images of BL21+NatB GFP cells 24 hours Post Induction, obtained using 
Phase and Fluorescent light microscopy (stained with FM4-64. Scale 1Pm), TEM and       
Immuno EM. 
GFP                      FM4-64                          Phase 
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 At 90 hours post induction, the second set of cells, for all five cultures were stained 
with FM4-64 and examined by phase and appropriate fluorescent microscopy and 
images taken. Images were also taken using TEM but not by Immuno EM (Figures 43 
to 47). Immuno EM images were not taken using the 90 hours post induction cells, as 
only the cells producing D-Synuclein-Cerulean3 had shown any labelling in the 24 
hours post induction samples. A reduced number of the 24 hours post induction cells 
showed labelling compared to the 2 hours 30 minutes post induction cells, that were 
initially imaged using Immuno EM, indicating that some of the cells may have lost 
plasmid. For both only the BL21+NatADS-Cerulean3 and BL21+NatBDS-Cerulean3 
cells all of the cells in 5 fields were counted according to whether they contained gold 
discs indicating the presence of D-Synuclein. 36% of the BL21+NatADS-Cerulean3 
cells, 39 out of 109 cells and 41% of the BL21+NatBDS-Cerulean3 cells 35 out of 86 
cells showed no immune labelling. The fluorescent images were also much fainter, 
and the BL21+NatADS and BL21+NatB GFP cells (Figures. 45 & 47) were seen to 
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Figure.43. Images of BL21+NatA DS-Cerulean3 cells 90 hours Post Induction, 
obtained using Phase and Fluorescent light microscopy (stained with FM4-64. Scale 
1Pm) and TEM. 
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Figure.44. Images of BL21+NatB DS-Cerulean3 cells 90 hours Post Induction, 
obtained using Phase and Fluorescent light microscopy (stained with FM4-64. Scale 
1Pm) and TEM. 
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Figure.45. Images of BL21+NatA DS cells 90 hours Post Induction, obtained using 
Phase and Fluorescent light microscopy (stained with FM4-64. Scale 1Pm) and TEM. 
What the spore like structures are is unknown. The white spots are holes where the 
resin used to fix the cells was unable to penetrate into these structures. 
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Figure.46. Images of BL21+NatB DS cells 90 hours Post Induction, obtained using 
Phase and Fluorescent light microscopy (stained with FM4-64. Scale 1Pm) and TEM. 
The images appear to show a large proportion of dead or dying cells.  
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Figure.47. Images of BL21+NatB GFP cells, 90 hours Post Induction, obtained using 
Phase and Fluorescent light microscopy (stained with FM4-64) and TEM. What the 
spore like structures are is unknown. The white spots are holes where the resin used 
to fix the cells was unable to penetrate into these structures 
GFP                                                            FM4-64         
 
Phase                                                               TEM 
        
 
   The cells expressing D-Synuclein without a fluorescent tag, produced such 
unexpected images, without blebbing or tubular structures like the as-Cer3 images, 
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and this together with the lack of labelling in the Immuno EM images, led to a suspicion 
that this plasmid did not contain the gene for the production of D-Synuclein as it was 
supposed to. 
  To investigate this suspicion, the 90 Hour protein samples precipitated from the cell 
cleared culture media were examined by Coomassie stained Gel and by Western Blot        
(Figure 48) using anti D-Synuclein antibody at a 1 in 1000 dilution.  
 
 
Figure.48. Coomassie stained 4-12% Bis-Tris gel and Western Blot analysis of cell 
cleared culture media, 90 Hours post induction.   
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 This examination of protein from the 90 hours post induction, cell cleared culture 
media, further indicated that D-Synuclein was only produced in the           
BL21+NatADS-Cerulean3 and BL21+NatBDS-Cerulean3 cells. This again suggests 
that the DS-plasmid given to this laboratory, did not contain the gene for the production 
of D-Synuclein. 
To finally confirm these suspicions, another matching Coomassie stained gel and 
Western Blot were performed, (Figure 49) this time using cells taken for protein 
examination Pre and 90 Hours post induction. 
 
Figure.49. Coomassie stained 4-12% Bis-Tris gel and Western Blot analysis of protein 
from cells taken, pre and 90 Hours post induction.   
 
 This second protein examination further indicated that D-Synuclein was only present 
in the BL21+NatADS-Cerulean3 and BL21+NatBDS-Cerulean3 cells. This result was 
taken to confirm that the DS-plasmid that had been given to the laboratory, did not 
contain the gene for the production of D-Synuclein.  
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4.11: Investigation into the role of D-Synuclein in Membrane 
reorganisation 
Having seen on the Electron Micrographs that the blebs produced by cells producing 
D-Synuclein appear to be membrane bound, it was decide to further investigate this 
by live cell imaging and fluorescent growth curves. 
A pETDuet vector was produced containing the genes for D-Synuclein-Cerulean3 and 





Figure. 50. Plasmid map for the pETDuet plasmid used for the production of just one 
or simultaneous production of two recombinant proteins. 
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Figure.51. Plasmid map showing the locations of the genes for D-Synuclein-
Cerulean3 and cydAB-mCherry proteins,within the pETDuet plasmid. 
 
A control pETDuet vector was produced which only contained the gene for cydAB-
mCherry. 
Images were taken of BL21DE3 and BL21DE3+NatB cells, with each of these vectors 
after 0.5 hours incubation in LB and antibiotic and then a further 1 hour incubation on 
a 1% agarose in LB and antibiotic slide. 
In the cells containing pDUETDS-Cerulean3+cydAB-mCherry expressing both             
D-Synuclein-Cerulean3 and cydAB-mCherry, much higher level of fluorescence were 
seen with the Cerulean3 than with the mCherry. The reason for this increase in 
mCherry fluorescence is at present unknown but is possibly due to interactions 
between the DS-Cer3 and the cell membranes. Many images show both Cerulean3 
and mCherry in the same location at membranes and externally, indicating the 
presence of membrane bound blebs, however other images show different areas of 
localisation with D-Synuclein appearing to be cytoplasmic within the plasma 
membrane. 
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Cerulean3                                 mCherry           . 
 
Combined image                                  Phase               . 
 
Figure.52. BL21DE3 DS-Cerulean3+cydAB-mCherry cells expressing both              
D-Synuclein-Cerulean3 and cydAB-mCherry The DS-Cer3 appears to be at lower 
levels in the cytoplasm and higher levels within blebs, cydAB-mCherry appears to be 
localised to the cell membrane. (Scale 1Pm) 
 
Cerulean3                                                    mCherry           . 
 
Combined image                                                   Phase             .       
 
Figure.53. BL21+NatB DS-Cerulean3+cydAB-mCherry cells expressing both          
D-Synuclein-Cerulean3 and cydAB-mCherry. The aS-Cer3 appears to be at slightly 
higher levels at cell membranes and at much higher levels in structures giving a 
stripy appearance to the brightest cell, cydAB-mCherry appears to be at slightly 
higher levels at cell membranes and poles. (Scale 1Pm).  
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Cerulean3                 mCherry                Combined image              Phase     . 
 
Figure.54. BL2+1NatB DS-Cerulean3+cydAB-mCherry cells expressing both               
D-Synuclein-Cerulean3 and cydAB-mCherry with the appearance of both ribbons and 
blebbing (Scale 1Pm). 
 
 Further images were taken to produce a direct comparison between the three vectors. 
pJC20DS-Cerulean3 producing D-Synuclein-Cerulean3, pDUETDS-
Cerulean3+cydAB-mCherry producing D-Synuclein-Cerulean3 and CydAB-mCherry 
simultaneously and pDUETcydAB-mCherry producing cydAB-mCherry, in both 
BL21DE3 cells to produce unacetylated D-Synuclein-Cerulean3 and in BL21+NatB 
cells to produce acetylated D-Synuclein-Cerulean3.   
Six cultures were set up, one for each of the combinations. At an OD600 of between 
0.51 and 0.63 each was induced by the addition of 1Pm per ml of IPTG (100mg/ml 
stock). They were then incubated at 37oC for 1.5 Hours. The broths were then used to 
make up slides on 2% agarose in LB broth containing the appropriate antibody and 
IPTG, and then incubated for a further 0.5 Hour at 37oC. 
Keeping all the microscope settings the same throughout, images were taken of 
Cerulean3 and mCherry signals, so that fluorescent intensities could be compared. 
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Figure.55. Images of BL21DE3 and BL2+1NatB cells with plasmids containing                
DS-Cerulean3, DS-Cerulean3+cydAB-mCherry or cydAB-mCherry genes. Cells are 
compared expressing either D-Synuclein-Cerulean3, cydAB-mCherry or both 
simultaneously. (Scale 1Pm, except where 5Pm stated on image).   









DS-Cerulean3        DS-Cerulean3 
+cydAB-mCherry      
cydAB-mCherry      
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 It was decided to obtain fluorescent growth curves for both Cerulean3 and mCherry 
simultaneously in the same six samples imaged earlier (Figures 56 & 57). 
A new culture of each of the six samples was grown in LB and appropriate antibiotic, 
until mid-log phase was reached. Each was then diluted according to its OD600 to 
obtain cultures at an OD600 of 0.1, and 0.1Pl per ml of IPTG (100mg/ml stock) was 
added. 1ml of each culture was then added to each of 4 wells on a 24 well plate, which 
was then placed in an automatic plate reader at 37oC with shaking and fluorescence 
readings for both Cerulean3 and mCherry were taken every 15 minutes. 
  
Figure.56. Cerulean3 fluorescent growth curve, for BL21DE3 and BL21+NatB cells 
with plasmids containing DS-Cerulean3, DS-Cerulean3+cydAB-mCherry or cydAB-
mCherry genes.   
 
 Cells expressing, cydAB-mCherry showed no increase in Cerulean3 fluorescence, as 
expected. The cells expressing D-Synuclein-Cerulean3 show the largest increase in 
Cerulean3 fluorescence, with the unacetylated producing more fluorescence than the 
acetylated. The cells producing both recombinant proteins simultaneously also 
showed an increase in fluorescence, of approximately half that measured for the cells 
producing D-Synuclein-Cerulean3 alone and again the BL21DE3 cells produced more 
fluorescence than the BL21DE3+NatB cells, possibly due to the extra stress placed 
upon the cells producing additional NatB complex .  
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Figure.57. mCherry Fluorescent growth curve, for BL21DE3 and BL21+NatB cells 
with plasmids containing DS-Cerulean3, DS-Cerulean3+cydAB-mCherry or cydAB-
mCherry genes.  
 
 
 The cells expressing D-Synuclein-Cerulean3 show no increase in mCherry 
fluorescence. Cells expressing just cydAB-mCherry show a clear increase in mCherry 
fluorescence, as expected, with the unacetylated producing more fluorescence than 
the acetylated. The cells producing both recombinant proteins simultaneously also 
showed an increase in mCherry fluorescence. The BL21+NatB DS-Cerulean3+cydAB-
mCherry cells showed a slightly higher level of mCherry fluorescence than that 
measured for the cells producing just cydAB-mCherry. The BL21DE3                       
DS-Cerulean3+cydAB-mCherry cells showed approximately double the increase in 
mCherry fluorescence than that measured for the cells producing cydAB-mCherry 
alone. This was just under double that measured in cells producing acetylated               
D-Synuclein-Cerulean3 and cydAB-mCherry. 
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 To confirm that the correct recombinant proteins were being produced with each 
vector, whole cell protein samples from each of the six cultures used for imaging and 
fluorescent growth curves were examined by Coomassie stained gel (Figure.58) along 




Figure.58. Coomassie stained gel for whole cell protein samples from BL21DE3 and 
BL21+NatB cells with plasmids containing DS-Cerulean3, DS-Cerulean3+cydAB-
mCherry and cydAB-mCherry genes, pre induction and 2 hours post induction. 
 




Figure.59. Coomassie stained  4-12% Bis-Tris gel for 5 day post induction protein 
samples from cell cleared culture medium from cultures of BL21DE3 and BL21+NatB 
cells containing DS-Cerulean3, DS-Cerulean3+cydAB-mCherry and cydAB-mCherry. 
 
  The Coomassie stained gels indicated induction of DS-Cerulean3 but no additional 
bands could be clearly seen, indicating the induction of cydAB-mCherry. The 2 hours 
post induction, whole cell protein samples, were used to carry out two Western Blots, 
one using anti D-Synuclein as the primary antibody and one using anti-mCherry as the 
primary antibody (Figure.60).  Appropriate bands were identified in the samples, 
confirming that DS-Cerulean3 and cydAB-mCherry were being expressed in the 
correct cultures. 




Figure.60. Western Blots using anti D-Synuclein (top) and anti mCherry (bottom) on 
whole cell protein samples taken 2 hours port induction from cultures of BL21DE3 and 
BL21+NatB cells containing DS-Cerulean3, DS-Cerulean3+cydAB-mCherry and 
cydAB-mCherry. 
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4.12: Investigation of Oligomer formation using 
Bimolecular Fluorescence Complementation (BiFC) 
 Having seen the presence of possible dimers and tetramers of D-Synuclein during the 
comparison of acetylated and unacetylated D-Synuclein produced in E.coli, it was 
decided to investigate oligomer formation using BiFC. The BiFC assay is a useful 
imaging tool for direct visualization of protein-protein interactions in living cells. It is 
based on the structural complementation of two nonfluorescent N- and C-terminal 
fragments of a fluorescent protein, when they are fused to a pair of interacting proteins. 
(Yutaka Kodama el al 2010) Previously BiFC has been used to investigate D-Synuclein 
oligomer formation (Outeiro et al, 2008, Roberts et al, 2015) however these 
investigations used GFP to fluorescently tag both the C and N terminal ends of                 
D-Synuclein. As we are examining the effect of N-terminal acetylation on membrane 
interactions and oligomer formation we only tagged the C-terminal of D-Synuclein. 
 Two new vectors were produced for the investigation, to create D-Synuclein fixed to 
half of a Yellow Fluorescent Protein, Venus. This was done using the pETDuet 
plasmid, so that either half of the Venus protein attached toD-Synuclein could be 
produced on its own or both could be produced simultaneously within the same cell. If 
D-Synuclein forms oligomers with a cell where D-Synuclein is attached to either half of 
the Venus protein, this should bring the two complementary halves of the Venus 
protein into close proximity, allowing the production of Venus fluorescence within the 
cell. 
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The vectors produced were 
1. pDUET-D-Synuclein-Venus-Carboxyl half (Ds-VC)  
 
2. pDUET-D-Synuclein-Venus-Amino half, D-Synuclein-Venus Carboxyl half                   
(DS-VN DS-VC) 
  
Figure. 61. Plasmid map to show the relative positions of the genes coding 
for D-Synuclein-Venus-Amino half and DSynuclein-Venus Carboxyl half  
within the pETDuet plasmid. 
 
3. pDUET a-Synuclein-Venus-Amino half (Ds-VN) 
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 The first two of these plasmids was transformed into BL21+NatA and BL21NatB E.coli 
cells to investigate the effect of acetylation on Oligomer formation. Cells in Log phase 
were induced with IPTG. Protein samples were taken pre and at 3 hours post induction 
and cells were examined by fluorescent microscopy at 3 hours post induction (Figures 
62 to 64). No fluorescence could be seen in cells containing DS-VC and only phase 
images could be taken (Figure 62). This confirmed that any oligomers formed with only 
the Carboxyl half of the Venus protein present did not produce fluorescence unlike 




Figure.62. Images of BL21+NatA (left) and BL21+NatB (right) cells containing    
DS-VC observed by Phase microscopy. No Venus signal was visible, showing that 
the Carboxyl half of the Venus Protein does not produce fluorescence by itself. 
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Figure.63. Images of BL21+NatA DS-VN DS-VC cells producing D-Synuclein-Venus 
Amino half and D-Synuclein-Venus Carboxyl half have Venus fluorescence, showing 
both blebbing around cells and a ribbon like appearance within many cells. This 
indicates the presence of D-Synuclein oligomers, both within the cells and within the 
blebs. 
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Phase                                               Venus       . 
 
 
Figure.64. Images of BL21+NatB DS-VN DS-VC  cells producing acetylated                   
D-Synuclein-Venus Amino half and acetylated D-Synuclein-Venus Carboxyl half also 
have Venus fluorescence, showing both blebbing around cells and a ribbon like 
appearance within cells. This again indicates the presence of D-Synuclein oligomers 
both within the cells and within the blebs (Scale 1Pm). 
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The whole cell protein samples taken pre and 3 hours post induction were examined 





Figure.65.  Coomassie stained 4-12% Bis-Tris gel examining BL21+NatADS-VC, 
BL21+NatBDS-VC, BL21+NatADS-VN DS-VC and BL21+NatBDS-VN DS-VC whole 
cell proteins, Pre and 3 Hours Post induction.  Post induction the DS-VC samples show 
the production of D-Synuclein-Venus-Carboxyl half (24.1kDa) and the DS-VN DS-VC 
samples show the production of both D-Synuclein-Venus-Carboxyl half and                    
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 To investigate the release of protein into the culture medium, precipitated protein 
samples from Cell cleared culture media, were taken the same as previously, at 24, 
48, 120 and 144 hours post induction, from BL21+NatADS-VN DS-VC and 
BL21Nat+BDS-VN DS-VC cultures. The protein samples were examined by 
Coomassie stained gel and Western Blot analysis, (Figure 66). Both show an 
increasing amount of protein being released into the supernatant, with a higher level 
being released from the BL21+NatADS-VN DS-VC cells, possibly including oligomers, 
at 144 hours.  
 
Figure.66. Coomassie stained 4-12% Bis-Tris gel and Western Blot, examining 
protein precipitated from, Cell cleared culture media from BL21+NatADS-VN DS-VC 
and BL21+NatBDS-VN DS-VC, cultures at 24, 48, 120 and 144 hours post induction. 
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 As a further control and for use in obtaining fluorescent growth curves a second single 
protein vector was produced, D-Synuclein-Venus-Amino half (DS-VN). Two cultures of 
BL21DE3DS-VC and BL21DE3DS-VN were grown until mid-log phase and induced 
with IPTG. Whole cell protein samples were taken pre induction and 2 hours post 
induction. These samples were examined using a Coomassie stained gel to confirm 





Figure.67. Coomassie stained 4-12% Bis-Tris gel showing separate production of 
D-Synuclein-Venus-Amino half and D-Synuclein-Venus-Carboxyl half in BL21DE3 
cells using vectors DS-VN and DS-VC. 
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 A culture of BL21DE3DS-VN was grown for 2.25 Hours then mounted on agarose 
and images taken. The BL21DE3DS-VN cells were imaged as a control to confirm 
that, as with the imaged cells containing DS-VC, no fluorescence could be seen and 
only phase images could be taken (Figure 68). This confirmed that any oligomers 
formed with only the Amino half of the Venus protein present, did not produce 
fluorescence unlike those containing the DS-VN DS-VC which produced clear 
fluorescence (Figures 63 & 64). 
 
                         Phase                                                             Venus        
 
 
Figure.68. Images of BL21DE3 cells containing DS-VN observed by Phase 
microscopy (left). No Venus signal was visible and so no images possible (right), 
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 A fluorescent growth curve was obtained for BL21DE3 and BL21+NatB cells 
containing DS-VC, DS-VN DS-VC and DS-VN vectors. Each of the six cultures was 
grown in LB broth with appropriate antibiotics added, until they reached mid log phase. 
Each was then diluted according to their OD600 to an OD600 of 0.1, and 0.1Pl per ml 
IPTG (100mg/ml stock) added. 1ml of each culture was then added to each of 4 wells 
on a 24 well plate which was then placed in an automatic plate reader at 37oC with 
shaking, and fluorescence readings for Venus were taken every 15 minutes 
(Figure.69). 
 
Figure.69. Venus fluorescent growth curve for BL21DE3 and BL21+NatB cells 
containing DS-VC, DS-VN DS-VC and DS-VN vectors. A gradual increase in 
fluorescence was seen with the cells containing DS-VC, and DS-VN vectors alone.  A 
rapid initial increase in fluorescence was seen with both cultures containing DS-VN 
DS-VC. This rate reduced after 3hours with BL21NatBDS-VN DS-VC cells and a 
decrease in fluorescence was seen with BL21DE3DS-VN DS-VC cells after 18 hours. 
 
Only a small very gradual increase in fluorescence was seen with the cells containing 
DS-VC, and DS-VN vectors alone.  A rapid increase in fluorescence was seen with 
both cultures containing DS-VN DS-VC. However, at 3 hours this rate of increase in 
fluorescence decreased sharply, with the BL21NatBDS-VN DS-VC cells, which then 
only showed a very gradual increase in fluorescence, which was slightly less than that 
of the cells containing DS-VC, and DS-VN vectors. This was in contrast to the 
BL21DE3DS-VN DS-VC cells which continued to show a strong increase in 
fluorescence until approximately 18 hours, at which point the level of fluorescence 
began to fall until it reached the same level as the BL21+NatBDS-VN DS-VC cells. 
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4.13: Purification of D-Synuclein-Cerulean3 from cell 
cleared culture media using dialysis, centrifugation and 
FPLC 
 Due to the levels of D-Synuclein in the cell cleared culture media as seen by 
Coomassie stained gels and Western blots, it was decided to try to purify D-Synuclein-
Cerulean3 from 200ml cultures grown in LB with appropriate antibiotics. If successful 
this could provide a gentle method for purifying larger amounts of acetylated                    
D-Synuclein including oligomers for further in vitro investigation. BL21+NatB DS-
Cerulean3 cells were grown for 4 days and then centrifuged to obtain cell cleared 
FXOWXUHPHGLDDQGWKHQSUHSDUHGIRUSXULILFDWLRQDQGUXQRQ)3/&DVLQWKHµ0DWHULDOV
DQG0HWKRGV¶)UDFWLRQV-WR-)LJXUH0) had a bright green colour and were also 
seen to have the largest amount of protein when fractions were examined by 
Coomassie stained gel (Figure.71). Fractions J2 and J4 were selected for further 
examination by Western Blot using anti D-Synuclein as the primary antibody (Figure 
72). Monomers were identified by the Western Blot, showing that D-Synuclein-
Cerulean3 was successfully purified, however as no dimers or tetramers were seen 
this purification method may be breaking these up. Further investigations will include 
looking for gentler methods of purification, which preserve dimers and tetramers.  
Unfortunately time restraints meant that mass spectrometry was not performed on this 
sample. However acetylated D-Synuclein has previously been produced successfully 
using this protocol, (Maltsev A.S. et al. 2012, Dikiy I. et al. 2014, Trexler A.J. et al 
2012). 
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Figure.70. FPLC trace showing protein containing fractions collected, determined by 
absorbance at 260 and 280nm, from purification of BL21+NatB DS-Cerulean3 Cell 
Cleared Culture Media. 
 
 
Figure.71. Coomassie stained 4-12% Bis-Tris gel showing protein content of fractions 
from purification of BL21+NatB DS-Cerulean3 from cell cleared culture media. 
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 Figure.72. Western Blot using anti D-Synuclein antibody on fractions J2 and J4 
(Figure 68) from the purification of BL21+NatB DS-Cerulean3 from cell cleared culture 
media. 
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5. CHAPTER V: DISCUSSION    
5.1 D-Synuclein in S.pombe cells 
D-Synuclein was successfully visualised inside S.pombe cells using DS-GFP,           
Ds-Cerulean3 and integrated DS-Cerulean3. The images obtained using                       
DS-Cerulean3 were clearer than those obtained using DS-GFP but both show similar 
distribution of D-Synuclein within the cell. At the levels produced, by the pREP41 
vector used during this project, D-Synuclein appears to remain cytoplasmic within 
S.pombe cells, but is excluded from vacuoles. Although some possible aggregates 
were seen these were few and small (Figures 8, 9, 14 & 19) and very similar to some 
of the cells expressing just GFP (figures 6 & 7) Localisation was seen in many cell at 
the separation membrane (Figures 17, 18 & 19) and occasionally at the poles (Figure 
20). However as in earlier work in S.pombe (Brandis K.A. et al 2006, Fiske M. et al 
2011), no cell membrane binding was seen, as in the many investigations using            
S. cerevisiae. D-Synuclein-GFP fusions have been used in several studies in yeasts 
previously to show D-Synuclein localisation and aggregation (Brandis K.A. et al 2006, 
Fiske M. et al 2011, Franssens V. et al 2013, Winderickx J. et al 2008), However the 
rapid aggreJDWLRQRIWKH$O]KHLPHU¶VSHSWLGH$E when fused to GFP has been shown 
to cause misfolding of GFP and a resultant lack of fluorescence. Future studies could 
investigate whether different forms of D-Synuclein oligomerisation effect the levels of 
fluorescence seen and fluorescent protein folding. 
 Average cell lengths for wild type cells containing GFP or DS-GFP grown either with 
or without thiamine were very similar. However in cells containing DS-GFP grown with 
thiamine, so that only very low levels of D-Synuclein were produced, a few unusually 
long cells were seen.  
 The three Western Blots performed on protein samples from S.pombe cells all 
indicated the presence of dimers. In wild type cells where the D-Synuclein produced 
is acetylated, dimers were found in the pellet sample, indicating that some of the 
dimers were membrane bound. But only a much smaller dimer band was seen in the 
pellet protein sample in comparison to that found in the cell supernatant in protein 
samples obtained from the naa25'S.pombe strain, where theD-Synuclein produced 
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remains unacetylated at its amino terminal methionine. This suggests that acetylation 
may stabilise dimers and membrane binding in S.pombe.  
 The OD600 growth curves show that for both wild type and naa25' strains of S.pombe 
containing DS-GFP grown without thiamine there is a significantly reduced maximum 
rate of growth.  Due to the very slow growth rate of the naa25' strain compared to that 
of the wild type, before any plasmids are introduced it is not possible to make a direct 
comparison of the two growth curves.  
 When DS-Cerulean3 was Integrated into the genome of wild type S.pombe it 
produced a consistently very low level of recombinant protein expression that was 
barely visible by fluorescent microscopy. However a very extreme phenotype was 
observed by Phase microscopy, to see more clearly how the cell was being affected 
FM4-64 stain was used. This showed the phenotype more clearly especially the 
presence of multiple septa, where the cells appeared to have difficulties completing 
cell division (Figures. 20 to 23) (Table.5). Also clear, large vacuoles were seen after    
1 day of incubation, but were only visible in a few cells after 2 days. This raises the 
question as to what happened to these structures between 1 and 2 days incubation 
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5.2 D-Synuclein within E.coli cells 
D-Synuclein was successfully visualised inside E.coli using both fluorescent 
microscopy, TEM and Immuno EM. The images obtained showed unexpected 
blebbing and structures within the cell, which indicated interactions between                  
D-Synuclein and the plasma membrane. This is discussed in more detail in section 
5.3. 
 Coomassie stained gels and Western blots again indicated the presence of 
monomers and dimers (Figures. 48, 49 & 60) and also indicate the presence of 
tetramers (Figure 33). This is discussed further in section 5.4 
 An OD600 growth curve (Figure 32) obtained from BL21+NatA and BL21+NatB cells, 
both uninduced and induced to produce acetylated or unacetylated D-Synuclein or 
empty vector, showed that  only the presence of acetylated D-Synuclein caused a 
significant reduction in the maximum rate of growth as measured by OD600. This was 
the same for both the induced and uninduced cells, suggesting that only a very low 
concentration of D-Synuclein needed to be present to cause this effect.  
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5.3 D-Synuclein membrane interactions within E.coli cells 
 The Blebbing and Ribbon like structures seen in the early fluorescent microscopy of 
cells producing D-Synuclein, indicated that D-Synuclein may be interacting with the 
plasma membrane, within E.coli. This was backed up by the TEM and immuno EM 
images, where blebs can be seen clearly coming out from the plasma membrane and 
the ribbon like structures were seen as tubular structures on the inside of the plasma 
membrane. This localisation was confirmed by the immuno EM images. 
The timing of the appearance of blebs followed by ribbons seemed to be inconsistent. 
Blebs were only observed within the first few hours post induction, mostly at 2 to 2.5 
hour post induction, though reduced numbers were seen before and after this time. 
Blebbing is seen most often in BL21DE3 and BL21+NatA cell suggesting that blebbing 
is produced less or over a shorter time span, in the presence of acetylated rather than 
unacetylated D-Synuclein. As blebbing is only seen relatively soon after induction it 
may be assumed that it occurs at relatively low D-Synuclein concentrations. At very 
low concentrations the amount of plasmid taken up by the cells may be having a 
significant effect on the rate that D-Synuclein is produced and therefore account for 
these time differences. The age of the culture may also effect the rate at which               
D-Synuclein is produced, as older cultures may be able to loose plasmid as is indicated 
by comparing the Immuno EM at 3 and 24 hours.    
D-Synuclein membrane interactions within E.coli cells were also investigated using 
BL21DE3 and BL21+NatB cells containing DS-Cerulean3, DS-Cerulean3 cydAB-
mCherry and cydAB-mCherry. The initial objective was to see if the higher levels of 
blebbing seen in BL21DE3 cells producing D-Synuclein, also resulted in an increase 
in membrane formation, indicated by an increase in mCherry fluorescence. From           
1 hour to 3.5 hours post induction the level of mCherry fluorescence within the 
BL21DE3 DS-Cerulean3 cydAB-mCherry culture increase at a significantly higher rate 
compared to all the other cultures. These time points also correspond to the times at 
which images of blebbing were taken. This rapid increase was not seen in BL21DE3 
cydAB-mCherry, only when D-Synuclein was also present in the cells. 
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5.4 D-Synuclein oligomer formation within E.coli cells 
 Using BiFC of split Venus fluorescent protein  fused to D-Synuclein to investigate 
oligomer formation proved very useful. The images obtained with the control vectors 
confirmed that no fluorescence could be obtained by inducing production of either half 
of the Venus protein alone. Although this construct was not expressed with a non-
interacting protein as a control it has been shown that this Venus protein has a reduced 
level of self assembly and so a decreased background fluorescence giving an 
increased signal-to noise ration compared to other fluorescent proteins used in BiFC 
assays, (Yutaka K. et al. 2010) The images  obtained for BL21+NatB DS-VN DS-VC 
and BL21+NatB DS-VN DS-VC cells showed very clear fluorescence within the cells 
and clear blebbing around them (Figures 63 & 64). As the two halves of the Venus 
protein only produce fluorescence when in very close proximity to each other, this 
result indicates that oligomers are being formed.  
 The fluorescent growth curve obtained using the same six cultures as were imaged, 
also confirmed a rapid increase in fluorescence for both for BL21DE3 and BL21+NatB 
cells with plasmids containing DS-VN DS-VC and only a minimal increase in cells 
where only one half of the Venus protein was present. After 3.5 hours induction there 
was a change in the rate of increase in fluorescence in the BL21+NatBDS-VN DS-VC 
cells, as the rate rapidly decreased to almost no change (Figure.69). The BL21DE3DS-
VN DS-VC cells in contrast continued to show an increase in fluorescence until 
approximately 18 hours post induction, achieving an increase in fluorescence of more 
than double that of the BL21+NatBDS-VN DS-VC cells, before falling again to return 
to the same level as the BL21+NatBDS-VN DS-VC cells by 39 hours post induction. 
This indicates that unacetylated D-Synuclein forms more or more stable oligomers 
than acetylated D-Synuclein. 
 In the western blot performed on the acetylated D-Synuclein after purification by FPLC 
only monomer D-Synuclein could be seen, whereas all the other Western Blots of 
protein from E.coli producing D-Synuclein had indicated the presence of dimers and 
possible tetramers. This suggests that oligomers are broken down during this 
purification method, future work will investigate alternative methods of protein 
purification. 
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5.5 Combined analysis of results 
 It has become clear from the results obtained in both S.pombe and in E.coli that only 
very low concentrations of D-Synuclein need to be present within cells to have a 
significant effect on the phenotype and behaviour of the cell. From the images taken 
and the growth curves obtained it appears that the concentration of D-Synuclein at 
which it causes these effects is exceeded after 3.5 hours post induction, when 
expressed in E.coli with the pDUET vector. The concentration of D-Synuclein that 
causes extreme phenotype, only appears to be reached in S.pombe when a single 
copy of the pINT vector was integrated into the S.pombe genome. When the pREP41 
vector was used in S.pombe, with unknown levels of uptake into the cell, higher levels 
of fluorescence were seen and the extreme phenotype was not seen. 
 Variation in plasmid copy number may also provide one explanation for the 
differences in the timing of the appearance of blebs, followed by ribbons in E.coli. The 
age of the culture may have a similar effect, as older cultures may be able to lose 
plasmid as is indicated by comparing the Immuno EM images at 3 and 24 hours. As 
blebbing is only seen relatively soon after induction it may be assumed that it occurs 
at relatively low D-Synuclein concentrations. At very low concentrations the amount of 
plasmid in the cells may have a significant effect on the rate that D-Synuclein is 
produced and therefore account for these time differences.  
 The effect of unacetylated D-Synuclein in E.coli at 3.5 hours post induction in 
BL21DE3 DS-Cerulean3 cydAB-mCherry and BL21DE3DS-VN DS-VC cells appears 
to be related, as the same vector and therefore the same promoter is used in each 
culture, it may be assumed that the concentrations of D-Synuclein would be similar in 
each. Beyond this time point, blebs were no longer seen by fluorescent microscopy 
and only a few smaller blebs were seen by TEM. It is at this time point that the rapid 
increase in mCherry fluorescence and therefore membrane formation which is 
possibly related to the blebbing decreases, it is also at this same time point that the 
rapid increase in Venus fluorescence and possibly related oligomer formation 
decreases. 
 The effect of acetylated D-Synuclein in E.coli appears to be very different. In 
BL21+NatB DS-Cerulean3 cydAB-mCherry the increase in mCherry fluorescence was 
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not seen (Figure.57). This is consistent with the fluorescent images, as blebbing was 
not seen as often, it seems to occur within a smaller time frame, and the blebs tend to 
be smaller, this is seen most clearly in the TEM images. The Venus Fluorescent growth 
curve was also very different between the cells producing acetylated and unacetylated 
D-Synuclein. Whereas the cells containing unacetylated only show a rapid increase in 
fluorescence for the first 3.5 hours post induction the cells producing acetylated            
D-Synuclein show a far more prolonged increase in fluorescence, up to 18 hours post 
induction (Figure.69). This indicates the formation of more or more stable oligomers. 
This is also consistent with the protein analysis. Clear indication of the presence of 
tetramers was only seen in whole cell protein samples examined by Coomassie 
stained gel and Western Blot (Figure.33) from BL21NatBDS-Cerulean3 cells. 
 
 In the OD600 growth charts obtained for E.coli and S.pombe, unexpectedly high final 
OD600 values were obtained for S.pombe, producing low levels of unacetylated               
D-Synuclein (Figure.13) and for E.coli producing unacetylated D-Synuclein (Figure 32). 
These results may be an inaccurate representation of cell growth and possible toxicity, 
due to the amount and size of blebbing seen with BL21DE3 DS-Cerulean3 and having 
observed the unusual phenotypes produced in wild type S.pombe with the expression 
of very low levels of D-Synuclein. Future investigations into the toxicity of D-Synuclein 
within E.coli and S.pombe may be more accurate if determined by the use of cell 
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5.6 Impact of this work 
 
In this project it has been shown that: 
A. D-Synuclein affects membrane dynamics. 
B. D-Synuclein alone can drive extracellular vesicle formation. 
C. These actions are regulated by D-Synuclein Nt-acetylation. 
 
 Previous in vivo studies of D-Synuclein have used a variety of cell lines and model 
organisms, including mice, Drosophila melanogaster, Caenorhabditis elegans and 
Saccharomyces cerevisiae (Franssens V. et al 2013). Only two previous studies using 
S.pombe have been found and none that have used E.coli as a model organism, 
though many have used E.coli for the expression of recombinant protein. Both 
S.pombe and E.coli have shown themselves to be useful model organisms for the in 
vivo study of D-Synuclein. E.coli has proven especially useful in comparing the effects 
of acetylated and unacetylated D-Synuclein and this work can hopefully be further 
expanded in S.pombe. 
 Much of the previous work in S. cerevisiae has focussed on membrane binding as a 
precursor to aggregate formation. In S.pombe no cell membrane and in E.coli no 
plasma membrane binding was seen, however in S.pombe with pREP41DS-Cerulean3 
localisation was seen at the separation membrane and at the poles. This indicates that 
the membrane binding of D-Synuclein is specific and by comparing different model 
organisms it may be possible to learn more about the differences in membrane 
structure and how these effect the binding and aggregate formation of D-Synuclein.  
 The concentration of D-Synuclein within both S.pombe and E.coli was found to 
significantly affect the phenotype and behaviour of the cells. Previous studies in 
S.pombe have looked at the effect of concentration of D-Synuclein, however one used 
a NMT1 high level expression vector, controlling expression with varying 
concentrations of thiamine (Fiske M. et al 2011). The other used different expression 
vectors to vary concentration, all without thiamine (Brandis K.A. et al 2006). In this 
project the extreme phenotype changes were only seen at very low levels of 
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expression, using an integrating vector, where the level of Cerulean3 fluorescence 
was only just visible. The images of Cerulean3 (Figures 20 to 23) required the 
brightness and contrast to be increased before inclusion in this thesis. It is possible 
that the level of D-Synuclein in the previous studies quickly exceeded the 
concentration at which these changes were seen. 
 In in vivo studies, wild type D-Synuclein is often compared to mutant forms of the 
protein. If the levels of protein expression are at a higher level than physiological, or 
even at a moderately high level within a model organism, this may in effect be the 
comparison of another disease state that does not represent normal D-Synuclein 
action. Duplications and triplications of the SNCA gene are associated with early onset 
3DUNLQVRQ¶V GLVHDVH VR LW PD\ EH DVVXPHG WKDW WKH FRQFHQWUDWLRQ RI D-Synuclein 
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5.7 Future work  
 This project has raised many questions that could be investigated in future work. 
 Firstly, why are different areas of localisation seen, why does D-Synuclein localise 
inside the plasma membrane of E.coli, as seen by Immuno EM and bind the cell 
membrane in S. cerevisiae, but not in S.pombe, what is different between the 
membranes and why is localisation seen at the separation membrane and poles in 
S.pombe. 
 The effect of very low concentrations of D-Synuclein appeared to be important. 
Further work investigating this could use different vectors to produce lower 
concentrations of D-Synuclein in S.pombe and E.coli. This could be used to investigate 
how a very low concentration of D-Synuclein over a longer period of time affects the 
cells. Would this extend the time period over which blebbing occurs in E.coli or the 
phenotype obtained in S.pombe. 
 Time lapse fluorescent microscopy may help gain a greater understanding of the 
timings of these effects. This could also be useful in co-localisation studies in S.pombe 
where cells produced unusual phenotypes including multiple septa. 
 Tetramer formation is another area for future investigation. Purification of D-Synuclein 
using FPLC appeared to destroy dimers and tetramers. Other methods of purification 
including purification using a His tag could be investigated to try to produce purified   
D-Synuclein containing tetramers. It may also be useful to find out why dimers and 
tetramers were lost during purification. 
Finally it would be useful to compare the toxicity of D-Synuclein in E.coli BL21DE3 & 
BL21+NatB by cell counts to see if the OD600 growth curves obtained were a true 
representation of growth or a measurement of blebbing.  
  
 113 | P a g e  
 
6. CHAPTER VI: REFERENCES  
Bartels T, Choi J.G, Selkoe D.J. ͞Į-Synuclein occurs physiologically as a helically 
folded tetramer that resists aggregation´Nature. 2011 August 14; 477(7362): 107±
110. 
Brandis KA, Holmes IF, England SJ, Sharma N, Kukreja L, DebBurman SK. ³alpha-
Synuclein fission yeast model: concentration-dependent aggregation without plasma 
membrane localization or toxicity.´J Mol Neurosci. 2006;28(2):179-91 
Burré J, Sharma M, Südhof TC.´Į-Synuclein assembles into higher-order multimers 
upon membrane binding to promote SNARE complex formation.´Proc Natl Acad Sci 
U S A. 2014 Oct 7;111(40):E4274-83 
Dikiy I, Eliezer D. ³N-terminal acetylation stabilizes N-terminal helicity in lipid- and 
micelle-ERXQG Į-synuclein and increases its affinity for physiological membranes.´
J Biol Chem. 2014 Feb 7;289(6):3652-65. 
Fauvet B, Fares MB, Samuel F, Dikiy I, Tandon A, Eliezer D, Lashuel HA.  
͞&KDUDFWHUL]DWLRQRIVHPLV\QWKHWLFDQGQDWXUDOO\1Į-DFHW\ODWHGĮ-synuclein in vitro and 
LQ LQWDFW FHOOV LPSOLFDWLRQV IRU DJJUHJDWLRQ DQG FHOOXODU SURSHUWLHV RI Į-synuclein.´      
J Biol Chem. 2012 Aug 17;287(34):28243-62.  
Fiske M, White M, Valtierra S, Herrera S, Solvang K, Konnikova A, Debburman S. 
³)DPLOLDO 3DUNLQVRQ
V 'LVHDVH 0XWDQW (. Į-Synuclein Localizes to Membranous 
Structures, Forms Aggregates, and Induces Toxicity in Yeast Models.´ISRN Neurol. 
2011;2011:521847. 
Franssens V, Bynens T, Van den Brande J, Vandermeeren K, Verduyckt M, 
Winderickx J. ͞The benefits of humanized yeast models to study Parkinson's disease.´
Oxid Med Cell Longev. 2013;2013:760629 
Johnson M, Coulton AT, Geeves MA, Mulvihill DP. ³Targeted amino-terminal 
acetylation of recombinant proteins in E. coli.´PLoS One. 2010 Dec 23;5(12):e15801. 
.LP:6.nJHGDO.+DOOLGD\*0³$OSKD-V\QXFOHLQELRORJ\LQ/HZ\ERG\GLVHDVHV´
Alzheimers Res Ther. 2014 Oct 27;6(5):73.  
 114 | P a g e  
 
Luth ES, Bartels T, Dettmer U, Kim NC, Selkoe DJ. ͞3XULILFDWLRQRIĮ-synuclein from 
human brain reveals an instability of endogenous multimers as the protein approaches 
purity.´Biochemistry. 2015 Jan 20;54(2):279-92. 
Maltsev AS, Ying J, Bax A. ³Impact of N-WHUPLQDO DFHW\ODWLRQ RI Į-synuclein on its 
random coil and lipid binding properties´Biochemistry. 2012 Jun 26;51(25):5004-13..    
Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, 
McLean PJ. ͞Formation of toxic oligomeric alpha-synuclein species in living cells.´ 
PLoS One. 2008 Apr 2;3(4):e1867. doi: 10.1371/journal.pone.0001867. 
Paleologou, Katerina E. (et al.) ³Į-Synuclein Aggregation and Modulating Factors´
Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease, 
Subcellular Biochemistry 65, 2012 
Polevoda B, Arnesen T, Sherman F. ³A synopsis of eukaryotic Nalpha-terminal 
acetyltransferases: nomenclature, subunits and substrates.´BMC Proc. 2009 Aug 4;3 
Suppl 6:S2 
Pratt MR, Abeywardana 70DURWWD13³6\QWKHWLF3URWHLQVDQG3HSWLGHVIRUWKH'LUHFW
,QWHUURJDWLRQRIĮ-6\QXFOHLQ3RVWWUDQVODWLRQDO0RGLILFDWLRQV´%LRPROHFXOHV-XQ
25;5(3):1210-27. 
Ritchie C.M, Thomas 3-³Alpha-synuclein truncation and disease´Health 
Vol.4 No.11A(2012), Article ID:24987, DOI:10.4236/health.2012.431175 
Roberts RF, Wade-Martins R, Alegre-Abarrategui J. ͞Direct visualization of alpha-
synuclein oligomers reveals previously undetected pathology in Parkinson's disease 
brain.´Brain. 2015 Jun;138(Pt 6):1642-57. doi: 10.1093/brain/awv040. Epub 2015 Mar 
1. 
Snead D, Eliezer ' ³Alpha-Synuclein Function and Dysfunction on Cellular 
Membranes´Exp Neurobiol. 2014 December; 23(4): 292±313. 
Trexler AJ, Rhoades E. ³N-7HUPLQDODFHW\ODWLRQLVFULWLFDOIRUIRUPLQJĮ-helical oligomer 
RIĮ-synuclein´Protein Sci. 2012 May;21(5):601-5. 
 Wang W, Perovic I, Chittuluru J, Kaganovich A, Nguyen LT, Liao J, Auclair JR, 
Johnson D, Landeru A, Simorellis AK, Ju S, Cookson MR, Asturias FJ, Agar JN, Webb 
 115 | P a g e  
 
BN, Kang C, Ringe D, Petsko GA, Pochapsky TC, Hoang QQ. ͞$VROXEOHĮ-synuclein 
construct forms a dynamic tetramer.´ Proc Natl Acad Sci U S A. 2011 Oct 
25;108(43):17797-802. 
Winderickx J, Delay C, De Vos A, Klinger H, Pellens K, Vanhelmont T, Van Leuven F, 
Zabrocki P. ͞Protein folding diseases and neurodegeneration: lessons learned from 
yeast.´Biochim Biophys Acta. 2008 Jul;1783(7):1381-95. 
Yutaka Kodama, Chang-Deng Hu ³An improved bimolecular fluorescence 
complementation assay with a high signal-to-noise ratio´BioTechniques 2010 49:793-
805. 
 
